<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25401" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Muscular Dystrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>LaPelusa</surname>
            <given-names>Andrew</given-names>
          </name>
          <aff>Charles R. Drew University of Medicine and Science</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Asuncion</surname>
            <given-names>Ria Monica D.</given-names>
          </name>
          <aff>University of Santo Tomas, Medicine and Surgery</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kentris </surname>
            <given-names>Michael</given-names>
          </name>
          <aff>Wright State University, Miami Valley Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew LaPelusa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ria Monica Asuncion declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Kentris declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25401.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Muscular dystrophy comprises a group of genetic disorders characterized by progressive muscle weakness and wasting, with a global incidence of approximately 1 in 5,000 individuals. While it can manifest at any age, it is most commonly diagnosed in childhood. The root cause of muscular dystrophy lies in mutations affecting genes responsible for muscle structure and function, leading to the gradual degeneration and loss of muscle fibers.</p>
        <p>Clinicians participating in this activity gain a comprehensive understanding of muscular dystrophy, including the global incidence, manifestation across ages, and the genetic basis involving mutations in muscle structure and function genes. The CE activity explores distinct hereditary patterns, emphasizing specific gene alterations leading to diverse manifestations. Participants learn about the impact on skeletal and cardiac muscles, disease progression, and associated complications, enhancing diagnostic and management skills for optimal patient care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the diverse pathophysiological mechanisms underlying various types of muscular dystrophy to enhance accurate and timely diagnoses.</p></list-item><list-item><p>Differentiate between different forms of muscular dystrophy, considering their unique patterns of inheritance, onset timing, and rates of muscle degeneration.</p></list-item><list-item><p>Implement a comprehensive multidisciplinary approach to care, integrating the expertise of different healthcare professionals for optimal patient management.</p></list-item><list-item><p>Coordinate care efficiently, considering the unique needs and challenges associated with muscular dystrophy, to provide comprehensive and patient-centered support.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25401&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25401">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25401.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Muscular dystrophy constitutes a group of genetic disorders characterized by progressive muscle weakness and wasting.&#x000a0;Muscular Dystrophy&#x000a0;affects approximately 1 in 5,000 individuals worldwide and can manifest at any age, although it is most&#x000a0;frequently diagnosed&#x000a0;during childhood. The cause of muscular dystrophy&#x000a0;is&#x000a0;mutations&#x000a0;affecting genes responsible&#x000a0;for muscle structure and function,&#x000a0;resulting in progressive&#x000a0;degeneration and loss of muscle fibers.</p>
        <p>The term "muscular dystrophy"&#x000a0;encompasses a&#x000a0;spectrum of hereditary disorders leading to progressive and&#x000a0;widespread muscle disease&#x000a0;due to&#x000a0;inadequate or&#x000a0;absent glycoproteins in the muscle cell plasma membrane.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;Muscular dystrophy&#x000a0;is a noncommunicable disorder with&#x000a0;numerous variations exhibiting unique patterns of inheritance, onset timing, and rate of muscle degeneration.<xref ref-type="bibr" rid="article-25401.r2">[2]</xref>&#x000a0;Distinct alterations in specific genes cause different manifestations of this disease.</p>
        <p>Muscular dystrophy affects skeletal and cardiac muscles. The progression of the condition varies depending on the type and severity of the disease but generally&#x000a0;follows a pattern of progressive muscle weakness,&#x000a0;reduced mobility, and the potential development of respiratory and cardiac complications.</p>
      </sec>
      <sec id="article-25401.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Muscular dystrophy can result from mutations in&#x000a0;various genes and&#x000a0;may be&#x000a0;inherited&#x000a0;in an X-linked, autosomal dominant, or autosomal recessive manner.<xref ref-type="bibr" rid="article-25401.r3">[3]</xref>&#x000a0;Changes in the X-linked gene DMD, which encodes dystrophin, are&#x000a0;the most frequent cause of muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r4">[4]</xref>&#x000a0;This is why the phenotype is manifested in hemizygous males, as they have only a single copy of the X chromosome.<xref ref-type="bibr" rid="article-25401.r5">[5]</xref>&#x000a0;It is important to note that mutations in dystrophin also create allelic heterogeneity.<xref ref-type="bibr" rid="article-25401.r6">[6]</xref>&#x000a0;Mutations in the DMD gene, for example, may&#x000a0;give rise to either&#x000a0;Duchenne or the less&#x000a0;severe Becker muscular dystrophy,&#x000a0;depending on the extent of the lack of protein.<xref ref-type="bibr" rid="article-25401.r7">[7]</xref>&#x000a0;</p>
        <p>Muscular dystrophy most often&#x000a0;results from defective or absent glycoproteins in the muscle membrane.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;Various types of muscular dystrophy&#x000a0;are&#x000a0;associated with&#x000a0;distinct gene deletions or mutations,&#x000a0;giving rise to diverse&#x000a0;enzymatic or metabolic defects.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref>&#x000a0;Notably, the&#x000a0;dystrophin gene is the largest in the human genome, with 79 exons.<xref ref-type="bibr" rid="article-25401.r9">[9]</xref>&#x000a0;Due to its immense size (&#x0003e;2 x 106 bases), the&#x000a0;dystrophin gene is&#x000a0;prone to a high rate of spontaneous mutations.<xref ref-type="bibr" rid="article-25401.r10">[10]</xref></p>
        <p>Insufficient levels of dystrophin result in damaged and ultimately dying muscle fibers, causing progressive muscle weakness, wasting, and fibrosis. This degenerative process can occur throughout the body, affecting various muscle groups and&#x000a0;giving rise&#x000a0;to different symptoms and complications.</p>
        <p>While the genetic mutations causing muscular dystrophy may differ, the underlying mechanism of muscle degeneration and loss&#x000a0;remains similar across all types of the disease. Early diagnosis, genetic testing, and appropriate management can help to improve outcomes and enhance the quality of life for individuals and families affected by muscular dystrophy.</p>
        <p>Although the phenotypic characteristics of&#x000a0;certain muscular dystrophies&#x000a0;are well-defined, the spectrum produced by mutations in various genes overlap,&#x000a0;leading&#x000a0;to nonallelic heterogeneity.<xref ref-type="bibr" rid="article-25401.r11">[11]</xref>&#x000a0;Recognizing&#x000a0;nonallelic heterogeneity is&#x000a0;crucial for&#x000a0;several reasons:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>The capacity to recognize disease loci in linkage studies is decreased by introducing subjects with associated phenotypes but separate genetic disorders.<xref ref-type="bibr" rid="article-25401.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Genetic testing becomes more complex&#x000a0;as&#x000a0;multiple&#x000a0;distinct genes need analysis along with the likelihood of&#x000a0;unique mutations in&#x000a0;each candidate gene.<xref ref-type="bibr" rid="article-25401.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Understanding how genes or proteins interact provides valuable insights into cell molecular physiology.<xref ref-type="bibr" rid="article-25401.r12">[12]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Phenocopies can arise when nongenetic diseases simulate the symptoms of a genetic disorder.<xref ref-type="bibr" rid="article-25401.r13">[13]</xref>&#x000a0;For instance, features of virus- or toxin-induced neurologic symptoms&#x000a0;may resemble those&#x000a0;observed in muscular dystrophy. Like&#x000a0;nonallelic heterogeneity, phenocopies&#x000a0;pose challenges in linkage studies and genetic testing.<xref ref-type="bibr" rid="article-25401.r13">[13]</xref>&#x000a0;However, careful consideration of patient&#x000a0;history and accurate differentiation in phenotype can usually render signs that&#x000a0;distinguish these disorders from similar genetic diseases.&#x000a0;It is important to note that muscular dystrophy&#x000a0;exhibits variable expressivity and incomplete penetrance, contributing to its manifestations across a phenotypic spectrum in&#x000a0;different affected individuals,&#x000a0;highlighting the concept of&#x000a0;variable expressivity.<xref ref-type="bibr" rid="article-25401.r14">[14]</xref><italic toggle="yes">&#x000a0;</italic>&#x000a0;</p>
        <p>
<bold>Modes of Inheritance&#x000a0;&#x000a0;</bold>
</p>
        <p>Muscular dystrophy exhibits various modes of inheritance, including autosomal dominant, autosomal recessive, and X-linked patterns, with specific subtypes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal dominant, autosomal recessive, X-linked:&#x000a0;
<list list-type="bullet"><list-item><p>Emery-Dreifuss&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal dominant, autosomal recessive
<list list-type="bullet"><list-item><p>Limb-Girdle (Dysferlinopathy, Erb)</p></list-item><list-item><p>Pelvifemoral</p></list-item><list-item><p>Scapulohumeral</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal dominant:&#x000a0;
<list list-type="bullet"><list-item><p>Facioscapulohumeral (Landouzy-Dejerine)</p></list-item><list-item><p>Late-onset distal (older than 40)</p></list-item><list-item><p>Myotonic</p></list-item><list-item><p>Oculopharyngeal</p></list-item><list-item><p>Scapuloperoneal</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal recessive:&#x000a0;
<list list-type="bullet"><list-item><p>Congenital</p></list-item><list-item><p>Early onset distal (younger than 40)</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>X-linked:&#x000a0;
<list list-type="bullet"><list-item><p>Becker (benign pseudohypertrophic)</p></list-item><list-item><p>Duchenne (pseudohypertrophic)</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Autosomal dominant, autosomal recessive, X-linked:</bold>
</p>
        <p>Emery-Dreifuss muscular dystrophy:<bold>&#x000a0;</bold>Attributed to&#x000a0;an&#x000a0;X-linked recessive&#x000a0;defect in the nuclear protein emerin&#x000a0;at the Xq27-28 position.<xref ref-type="bibr" rid="article-25401.r15">[15]</xref>&#x000a0;This variant can also&#x000a0;arise from an autosomal recessive or autosomal dominant&#x000a0;defect in inner nuclear lamina proteins lamin A/C&#x000a0;on chromosome 1.<xref ref-type="bibr" rid="article-25401.r16">[16]</xref></p>
        <p>
<bold>Autosomal dominant, autosomal recessive inheritance:&#x000a0;</bold>
</p>
        <p>Limb-Girdle Muscular Dystrophy:<bold>&#x000a0;</bold>Primarily exhibits&#x000a0;an autosomal recessive inheritance pattern but can&#x000a0;also occur in an autosomal dominant manner.<xref ref-type="bibr" rid="article-25401.r17">[17]</xref>&#x000a0;The age of onset varies, and the&#x000a0;distribution of involved muscles includes the limbs and trunk, often displaying a heterogeneous phenotype.<xref ref-type="bibr" rid="article-25401.r17">[17]</xref>&#x000a0;The recessive form of the disease tends to have an earlier onset and a more rapid progression, while the dominant form follows a slower and more variable course.<xref ref-type="bibr" rid="article-25401.r3">[3]</xref>&#x000a0;</p>
        <p>Multiple&#x000a0;genes have been implicated in this disease, with deficiencies identified in proteins such as sarcoglycan, calpain, dystroglycan, and dysferlin.<xref ref-type="bibr" rid="article-25401.r18">[18]</xref>&#x000a0;There is also potential involvement of&#x000a0;telethonin, lamin A/C, myotilin, and caveolin-3 (see <bold>Table.</bold> Limb-Girdle Muscular Dystrophy Subtype and Gene Abnormality).<xref ref-type="bibr" rid="article-25401.r19">[19]</xref>&#x000a0;</p>
        <table-wrap id="article-25401.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1. Limb-Girdle Muscular Dystrophy Subtype and Gene Abnormality</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">
<bold>Limb-Girdle Muscular Dystrophy Subtype</bold>
</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">
<bold>Gene&#x000a0;Deletion/Mutation</bold>
</td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">1A</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Myotilin deletion&#x000a0;<xref ref-type="bibr" rid="article-25401.r20">[20]</xref>&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">1B</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Lamin A/C gene deletion&#x000a0;<xref ref-type="bibr" rid="article-25401.r21">[21]</xref>&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">1C</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Caveolin 3 gene deletion&#x000a0;<xref ref-type="bibr" rid="article-25401.r22">[22]</xref></td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">2A</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Calpain gene mutation&#x000a0;<xref ref-type="bibr" rid="article-25401.r23">[23]</xref>&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">2B</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Dysferlin gene deletion&#x000a0;<xref ref-type="bibr" rid="article-25401.r24">[24]</xref>&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">
<p>2C</p>
<p>2D</p>
<p>2E</p>
<p>2F</p>
</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Sarcoglycan gene deletion&#x000a0;<xref ref-type="bibr" rid="article-25401.r25">[25]</xref><xref ref-type="bibr" rid="article-25401.r26">[26]</xref><xref ref-type="bibr" rid="article-25401.r27">[27]</xref><xref ref-type="bibr" rid="article-25401.r28">[28]</xref></td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">2G</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">Telethonin gene mutation&#x000a0;<xref ref-type="bibr" rid="article-25401.r29">[29]</xref></td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">2H</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">TRIM32 (tripartite motif-containing) gene 32 mutation&#x000a0;<xref ref-type="bibr" rid="article-25401.r30">[30]</xref>&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 164.625px;" rowspan="1" colspan="1">2I</td>
                <td style="width: 144.375px;" rowspan="1" colspan="1">&#x000a0;
<p>Fukutin-related protein gene deletion.<xref ref-type="bibr" rid="article-25401.r31">[31]</xref></p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Autosomal dominant inheritance:</bold>
</p>
        <p>Facioscapulohumeral muscular dystrophy:<bold>&#x000a0;</bold>Attributed to an&#x000a0;autosomal dominant&#x000a0;deletion of a 3.3 kb repeat on&#x000a0;chromosome 4.<xref ref-type="bibr" rid="article-25401.r32">[32]</xref>&#x000a0;Approximately&#x000a0;95% of cases&#x000a0;result&#x000a0;from&#x000a0;a mutation in the D4Z4&#x000a0;region, leading to facioscapulohumeral muscular dystrophy 1.<xref ref-type="bibr" rid="article-25401.r33">[33]</xref>&#x000a0;Other areas, such as the SMCHD1 region in the type 2 subtype, can also cause this disease.<xref ref-type="bibr" rid="article-25401.r34">[34]</xref>&#x000a0;The age of onset is between 10&#x000a0;and 30 years,&#x000a0;and the distribution of affected muscles involved includes the face, neck, and shoulders.<xref ref-type="bibr" rid="article-25401.r33">[33]</xref></p>
        <p>Myotonic muscular dystrophy:&#x000a0;Myotonic muscular dystrophy, or myotonic dystrophy, results from impaired dystrophia myotonica protein kinase&#x000a0;(DMPK) expression.<xref ref-type="bibr" rid="article-25401.r35">[35]</xref>&#x000a0;It is caused by an autosomal dominant, abnormally expanded CTG trinucleotide repeat sequence&#x000a0;located in the 3&#x02032; untranslated region of the DMPK gene.<xref ref-type="bibr" rid="article-25401.r36">[36]</xref>&#x000a0;Due to the expansion of&#x000a0;trinucleotide repeat sequences (CTG),&#x000a0;a phenomenon&#x000a0;known as amplification and anticipation occurs, where family members develop the disease at&#x000a0;progressively&#x000a0;earlier ages across generations.<xref ref-type="bibr" rid="article-25401.r37">[37]</xref>&#x000a0; Clinical severity increases&#x000a0;with the number of nucleotide repeats, with some cases&#x000a0;involving&#x000a0;thousands of repeats.<xref ref-type="bibr" rid="article-25401.r38">[38]</xref>&#x000a0;The age of onset is approximately 10 to 15 years,&#x000a0;and the distribution of&#x000a0;affected muscles includes the face and extremities. This defect is classically associated with chromosome 19; however, a&#x000a0;second form can occur on chromosome 3q.<xref ref-type="bibr" rid="article-25401.r39">[39]</xref><xref ref-type="bibr" rid="article-25401.r40">[40]</xref></p>
        <p>Oculopharyngeal muscular dystrophy: Typical&#x000a0;onset around 30&#x000a0;to 40 years, with affected muscles including the extraocular and pharyngeal muscles. This condition is caused by an autosomal dominant&#x000a0;GCG trinucleotide repeat, resulting in deficient mRNA transfer from the nucleus.<xref ref-type="bibr" rid="article-25401.r41">[41]</xref></p>
        <p>
<bold>Autosomal</bold>
<bold>&#x000a0;recessive inheritance:</bold>
</p>
        <p>Congenital muscular dystrophy:<bold>&#x000a0;</bold>Caused by a&#x000a0;mutation&#x000a0;of the sarcolemmal protein merosin gene. Additionally, deficiencies or mutations in laminin-alpha 2, collagen type VI, integrin-alpha 7, and glycosyltransferases can contribute to the manifestation of this disorder.<xref ref-type="bibr" rid="article-25401.r42">[42]</xref></p>
        <p>
<bold>X-linked inheritance:</bold>
</p>
        <p>Becker Muscular Dystrophy:&#x000a0;Caused by a mutation&#x000a0;in the&#x000a0;muscle protein dystrophin gene, which&#x000a0;codes for the protein dystrophin and is notably the largest in humans with&#x000a0;79 exons.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref>&#x000a0;The gene is transmitted in an&#x000a0;X-linked re&#x000ad;cessive manner, located on the X chromosome's small arm (p) at the Xp21 locus position.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref><xref ref-type="bibr" rid="article-25401.r43">[43]</xref>&#x000a0;In the absence of dystrophin, muscle cells deteriorate or die. The age of onset is 10 to 20 years,&#x000a0;and the distribution of involved muscles is generalized.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;</p>
        <p>Duchenne muscular dystrophy:&#x000a0;Caused by a dystrophin gene mutation located on the small arm of the X chromosome at the Xp21 position.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref>&#x000a0;A spontaneous mutation occurs in a third of cases, while X-linked maternal-fetal transmission accounts for two-thirds of cases.<xref ref-type="bibr" rid="article-25401.r44">[44]</xref><xref ref-type="bibr" rid="article-25401.r45">[45]</xref> This mutation results in a nonfunctional dystrophin protein,&#x000a0;leading to effects similar to those observed&#x000a0;in Becker muscular dystrophy. The age of onset is&#x000a0;typically around 3 to 5 years,&#x000a0;and the distribution of involved muscles is generalized.<xref ref-type="bibr" rid="article-25401.r42">[42]</xref>&#x000a0;</p>
        <p>In females with&#x000a0;Duchenne muscular dystrophy, an error in somatic cells&#x000a0;leads to the inactivation of&#x000a0;1 X-chromosome at an early stage, creating a mosaic representation of heterozygous X-linked genes.&#x000a0;While this condition generally protects female heterozygotes from X-linked disorders affecting males, X-inactivation in the female carrier&#x000a0;with an X-autosome translocation can sometimes create a lethal genetic imbalance in half of the body's cells, causing cell death. Consequently, the same X-chromosome is expressed in every cell, and if&#x000a0;it&#x000a0;carries a disease allele, the individual can express the X-linked disease&#x000a0;similarly to&#x000a0;males. This phenomenon explains some&#x000a0;cases of Duchenne muscular dystrophy in females.<xref ref-type="bibr" rid="article-25401.r46">[46]</xref></p>
      </sec>
      <sec id="article-25401.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Muscular dystrophy is a relatively rare condition, affecting an estimated 1 in every 5,000 to 10,000 individuals worldwide. In the&#x000a0;US, approximately 250,000 individuals are estimated to be living with muscular dystrophy or a related neuromuscular disorder. However, obtaining accurate prevalence estimates is challenging due to factors such as the wide range of disease severity,&#x000a0;variations in the age of onset, and the complexity of genetic testing required for diagnosis. Furthermore, the prevalence of the disease varies depending on the specific type of muscular dystrophy and the characteristics of the population being studied.</p>
        <p>Duchenne muscular dystrophy is the most common type of muscular dystrophy&#x000a0;observed in children, affecting approximately 1 in every 3,500 to 5,000 male births worldwide. Primarily affecting boys,&#x000a0;the onset of Duchenne muscular dystrophy typically occurs between the ages of 3 and 5 years.&#x000a0;The condition is progressive and ultimately fatal, with most individuals with Duchenne muscular dystrophy surviving into their&#x000a0;late teens or early 20s.</p>
        <p>Becker muscular dystrophy is a milder form resulting from mutations in the same DMD gene. This condition affects approximately 1 in every 18,000 to 30,000 individuals worldwide,&#x000a0;predominantly&#x000a0;males.&#x000a0;Becker muscular dystrophy typically has a later onset and milder course than Duchenne muscular dystrophy, with individuals often able to maintain ambulation into adulthood.</p>
        <p>Limb-girdle muscular dystrophy is a group of inherited muscular dystrophies that primarily impact the muscles of the hip and shoulder girdles.&#x000a0;Presently, there are over 30 subtypes of limb-girdle muscular dystrophy, each&#x000a0;arising&#x000a0;from gene mutations. The prevalence of&#x000a0;limb-girdle muscular dystrophy varies&#x000a0;based on the specific subtype, but it is estimated to be approximately 1 in every 14,500 to 123,000 individuals worldwide.</p>
        <p>Facioscapulohumeral muscular dystrophy is another type of muscular dystrophy that affects approximately 1 in every 20,000 individuals worldwide.&#x000a0;Facioscapulohumeral muscular dystrophy&#x000a0;typically&#x000a0;presents&#x000a0;with a later onset and slower progression than other types of muscular dystrophy, with symptoms often&#x000a0;emerging in the teenage or adult years. This condition is caused by mutations in the DUX4 gene, which&#x000a0;results in&#x000a0;inappropriate expression of a toxic protein in muscle cells.</p>
        <p>Muscular dystrophy&#x000a0;more commonly affects males than females, as many genetic mutations responsible for the condition are on the X chromosome. However, some forms of muscular dystrophy, such as limb-girdle muscular dystrophy,&#x000a0;exhibit an equal prevalence in both males and females. This is outlined below as follows:</p>
        <p>
<bold>Muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Most common childhood muscular dystrophy:&#x000a0;Duchenne&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Most common adult muscular dystrophy:&#x000a0;Myotonic&#x000a0;<xref ref-type="bibr" rid="article-25401.r47">[47]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prevalence of muscular dystrophy (general population):&#x000a0;16&#x000a0;to 25.1 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r48">[48]</xref><xref ref-type="bibr" rid="article-25401.r49">[49]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Frequency of muscular dystrophy (general population): 1 per 3,000&#x000a0;to 8,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r50">[50]</xref><xref ref-type="bibr" rid="article-25401.r51">[51]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Incidence of muscular dystrophy (male births):&#x000a0;1 per 5,000 or 200 per 1,000,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r52">[52]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Becker muscular dystrophy&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 4.78 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref></p>
          </list-item>
          <list-item>
            <p>Frequency (live male births): 1 per 18,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r54">[54]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Incidence (live male births):&#x000a0;1 per&#x000a0;5618&#x000a0;<xref ref-type="bibr" rid="article-25401.r54">[54]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Congenital muscular dystrophy&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 0.99 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prevalence (children): 0.82 Per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prevalence (general population-Italy): 1 per 16,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r55">[55]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Incidence (general population-Italy): 0.563&#x000a0;per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r56">[56]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Duchenne muscular dystrophy&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 4.78 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Frequency (general population): 13&#x000a0;to 33 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r57">[57]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Frequency (males): 1 per 3,500&#x000a0;<xref ref-type="bibr" rid="article-25401.r4">[4]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Incidence (live male births): 1 per 5,136&#x000a0;<xref ref-type="bibr" rid="article-25401.r52">[52]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Emery-Dreifuss muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 0.39 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prevalence (children): 0.22 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Facioscapulohumeral muscular dystrophy&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 3.95 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref></p>
          </list-item>
          <list-item>
            <p>Prevalence (children): 0.29&#x000a0;per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Limb-Girdle muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 1.63 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prevalence (children):&#x000a0;0.48 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Myotonic muscular dystrophy&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 8.26 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Prevalence (Children): 1.41 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r53">[53]</xref></p>
          </list-item>
        </list>
        <p><bold>Oculopharyngeal muscular dystrophy</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevalence (general population): 0.13 per 100,000&#x000a0;<xref ref-type="bibr" rid="article-25401.r58">[58]</xref></p>
          </list-item>
        </list>
        <p>*US, England, Australia, &#x00026; Canada unless otherwise specified*&#x000a0;</p>
      </sec>
      <sec id="article-25401.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There are several types of muscular dystrophy, each&#x000a0;characterized by its unique&#x000a0;genetic mutation and pathophysiology. Nevertheless, all&#x000a0;forms of muscular dystrophy&#x000a0;share a common feature: the progressive loss of muscle mass and strength.</p>
        <p>In addition to the absence of dystrophin, the pathophysiology of muscular dystrophy involves a cascade of events that lead to muscle fiber damage and loss. The&#x000a0;lack of dystrophin causes increased membrane permeability in muscle fibers,&#x000a0;enabling calcium ions to enter the cell and activate enzymes that degrade the muscle fiber structure. This inflammation and degeneration of muscle fibers&#x000a0;initiate a regeneration process by satellite cells. However, over time, this&#x000a0;regeneration becomes less efficient,&#x000a0;contributing to progressive muscle fiber loss and the development of fibrosis.</p>
        <p>Typical findings in muscular dystrophy include muscle weakness and wasting, particularly in the proximal muscles of the lower limbs, pelvic girdle, and shoulders. Individuals affected by the condition&#x000a0;may encounter challenges in&#x000a0;movement, including running, jumping, and climbing stairs,&#x000a0;along with muscle cramps and stiffness.&#x000a0;With&#x000a0;disease progression, respiratory and cardiac complications may arise due to the&#x000a0;engagement&#x000a0;of muscles responsible for breathing and heart function.</p>
        <p>
<bold>Muscle Contraction</bold>
</p>
        <p>It is&#x000a0;crucial to grasp the fundamental physiology of muscle cell function initially. The sliding filament model represents muscle tension as a function dependent on the contraction of the muscle filaments. This contraction is facilitated by calcium released&#x000a0;from the sarcoplasmic reticulum,&#x000a0;leading to muscle depolarization. Intracellular calcium binds to the anionic charge of troponin C,&#x000a0;causing the&#x000a0;displacement of tropomyosin from the G-actin site. Once exposed, a myosin head attaches to the&#x000a0;exposed G-actin site, initiating a pivot that requires energy from adenosine triphosphate (ATP). This pivot allows actin filaments to slide past myosin filaments, resulting in muscle shortening, transmitted to the muscle cell's glycoprotein-rich cytoskeleton.</p>
        <p>
<bold>Dystrophin<italic toggle="yes">&#x000a0;</italic></bold>
</p>
        <p>Dystrophin is&#x000a0;localized to the cytoplasmic surface of the muscle fiber plasma membrane, forming connections between the internal cytoskeleton&#x000a0;and the extracellular matrix&#x000a0;through glycoproteins that traverse the plasma membrane.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref>&#x000a0;This cytoskeletal protein&#x000a0;provides structural stability to a protein (dystroglycan) complex within cell membranes.<xref ref-type="bibr" rid="article-25401.r59">[59]</xref>&#x000a0;Specifically, dystrophin anchors the actin cytoskeleton to the basement membrane within a membrane-glycoprotein complex.<xref ref-type="bibr" rid="article-25401.r59">[59]</xref> Dystrophin, laminin, and other proteins constitute this cytoskeletal framework.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref>&#x000a0;Dystrophin&#x000a0;interacts with F-actin and &#x003b2;-dystroglycan, binding to &#x003b1;-dystroglycan and laminin within the extracellular matrix.<xref ref-type="bibr" rid="article-25401.r8">[8]</xref><xref ref-type="bibr" rid="article-25401.r60">[60]</xref>&#x000a0;The primary role of dystrophin is to secure the cytoskeleton to the extracellular matrix,<xref ref-type="bibr" rid="article-25401.r8">[8]</xref>&#x000a0;and&#x000a0;any dysfunction in dystrophin alters tension transmission in contracting muscles.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;</p>
        <p>When dystrophin is not functioning correctly, the contractile actin and myosin proteins, which generally shorten during muscle contraction, lead to both muscle weakness and injury to the cell membrane. This damage causes creatine kinase (CK) to leak&#x000a0;from every damaged muscle cell,&#x000a0;resulting in abnormally high levels&#x000a0;of CK in the plasma.<xref ref-type="bibr" rid="article-25401.r61">[61]</xref>&#x000a0;The release of CK incites an inflammatory response, promoting scar tissue formation and leading to the classic pseudohypertrophy of calf muscles&#x000a0;associated with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r62">[62]</xref>&#x000a0;Despite the appearance of hypertrophied muscles, there is a deficiency in functioning contractile filaments in the tissue, creating weak muscles.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;The&#x000ad; deficit is present from fetal development onwards.<xref ref-type="bibr" rid="article-25401.r63">[63]</xref>&#x000a0;Phago&#x000ad;cytosis of the damaged muscle cells by inflammatory cells&#x000a0;further contributes to scar&#x000ad;ring and impaired muscle function.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref></p>
        <p>
<bold>Dystrophin-Glycoprotein Complex</bold>
</p>
        <p>This protein meshwork formed by dystrophin and associated proteins appears to strengthen the sarcolemma.<xref ref-type="bibr" rid="article-25401.r64">[64]</xref>&#x000a0;The loss of 1 component of this network may&#x000a0;trigger changes in other elements. For instance,&#x000a0;the initial loss of dystrophin may&#x000a0;result in the&#x000a0;breakdown of sarcoglycans, including&#x000a0;dystroglycan.<xref ref-type="bibr" rid="article-25401.r65">[65]</xref>&#x000a0;The&#x000a0;weakened&#x000a0;membrane ultimately leads to&#x000a0;muscle cell death.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;Fat and connective tissue gradually replace skeletal muscle, resulting in significant muscle atrophy.<xref ref-type="bibr" rid="article-25401.r66">[66]</xref>&#x000a0;This skeletal muscle deterioration&#x000a0;leads to deformities in the skeleton, causing gradual immobility. Car&#x000ad;diac and smooth muscle&#x000a0;in the gastrointestinal tract&#x000a0;commonly&#x000a0;undergo fibrosis.<xref ref-type="bibr" rid="article-25401.r67">[67]</xref> The brain&#x000a0;may exhibit structural abnormalities with no&#x000a0;consistent&#x000a0;pattern.<xref ref-type="bibr" rid="article-25401.r67">[67]</xref></p>
      </sec>
      <sec id="article-25401.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>The toxicokinetics of muscular dystrophy involve complex interactions&#x000a0;among genetic, environmental, and immune factors, resulting in muscle weakness and degeneration. Additional research is needed to fully understand these mechanisms and develop more effective treatments for this debilitating condition.</p>
        <p>
<bold>Environmental Factors</bold>
</p>
        <p>Physical activity and nutrition&#x000a0;could potentially influence the&#x000a0;toxicokinetics of muscular dystrophy. Increased physical activity may elevate oxidative stress and inflammation, potentially worsening&#x000a0;muscle damage in individuals with muscular dystrophy.&#x000a0;Conversely, proper nutrition, with adequate protein and essential nutrients,&#x000a0;might contribute&#x000a0;to maintaining muscle mass and function.</p>
        <p>
<bold>Inflammation</bold>
</p>
        <p>Chronic inflammation&#x000a0;has the potential to&#x000a0;activate immune cells, release inflammatory cytokines, and promote muscle damage and degeneration. In some cases,&#x000a0;the accumulation of abnormal proteins in muscle cells may trigger inflammation.</p>
        <p>
<bold>Malignant Hyperthermia</bold>
</p>
        <p>This is a unique and life-threatening myopathy that can occur in genetically susceptive individuals following exposure to triggering factors,&#x000a0;typically halogenated anesthetic gases like halothane, isoflurane, sevoflurane, and desflurane.<xref ref-type="bibr" rid="article-25401.r68">[68]</xref>&#x000a0;Additionally, exposure to succinylcholine can also induce this condition.<xref ref-type="bibr" rid="article-25401.r69">[69]</xref>&#x000a0;In&#x000a0;individuals with dystrophinopathies, the administration of these agents can lead&#x000a0;to rhabdomyolysis, prompting many experts to advocate for the exclusive use of nontriggering agents.</p>
        <p>Malignant hyperthermia&#x000a0;occurs due&#x000a0;to&#x000a0;abnormal calcium&#x000a0;regulation&#x000a0;associated with dystropinopathies. Dysregulated calcium release of the sarcoplasmic reticulum, coupled with anesthetic-induced interference&#x000a0;in calcium reuptake, results in&#x000a0;persistent muscle contraction, prolonged aerobic and anaerobic metabolism, increased carbon dioxide production, elevated end-tidal carbon dioxide, and tachycardia in these individuals who are unable to increase their alveolar minute volume adequately. This hypermetabolism generates an exponentially dangerous amount of heat, overwhelming the body's capacity to dissipate it effectively.</p>
      </sec>
      <sec id="article-25401.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The onset of muscular dystrophy usually occurs&#x000a0;in the third&#x000a0;to fourth decades of life.<xref ref-type="bibr" rid="article-25401.r47">[47]</xref>&#x000a0;However, it may&#x000a0;also become apparent in infancy or&#x000a0;undergo accelerated deterioration near onset.<xref ref-type="bibr" rid="article-25401.r39">[39]</xref>&#x000a0;Parents of affected individuals may&#x000a0;express concerns&#x000a0;about their child's walking ability compared to peers of the same age.<xref ref-type="bibr" rid="article-25401.r70">[70]</xref><xref ref-type="bibr" rid="article-25401.r71">[71]</xref>&#x000a0;The child may&#x000a0;encounter difficulties in activities like kicking a ball due to muscle weakness.<xref ref-type="bibr" rid="article-25401.r72">[72]</xref>&#x000a0;Pseudo-drop events&#x000a0;resulting from weakness of the quadriceps muscle may also be observed.<xref ref-type="bibr" rid="article-25401.r73">[73]</xref>&#x000a0;Notably, both&#x000a0;parents could be in good health.<xref ref-type="bibr" rid="article-25401.r74">[74]</xref>&#x000a0;</p>
        <p>During a&#x000a0;physical examination, individuals affected by muscular dystrophy&#x000a0;typically&#x000a0;exhibit pronounced calf muscle enlargement along with weakness in the proximal muscles of the lower limbs.<xref ref-type="bibr" rid="article-25401.r75">[75]</xref>&#x000a0;Consequently, affected individuals often rely on&#x000a0;their arms and hands&#x000a0;for assistance when&#x000a0;rising from a seated position.<xref ref-type="bibr" rid="article-25401.r76">[76]</xref>&#x000a0;Other complaints include a history of delayed ambulation, toe walking, calf hypertrophy, and proximal hip girdle muscle instability.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0;</p>
        <p>Presentations may also&#x000a0;include asymptomatic elevation of serum creatine kinase (CK), exertion intolerance, dilated cardiomyopathy, malignant hyperthermia, quadriceps myopathy, language delay, and in rare cases, Turner syndrome in X chromosome monozygotic females with Duchenne muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r78">[78]</xref>&#x000a0;In some individuals with subclinical muscular dystrophy, the diagnosis may initially be suspected&#x000a0;based on family history or the&#x000a0;presence of&#x000a0;elevated liver enzymes. However, the underlying cause of these enzyme elevations is not always clear.<xref ref-type="bibr" rid="article-25401.r79">[79]</xref>&#x000a0;These enzymes may include alanine aminotransferase and aspartate aminotransferase.<xref ref-type="bibr" rid="article-25401.r79">[79]</xref>&#x000a0;</p>
        <p>Given&#x000a0;the X-linked inheritance pattern of&#x000a0;muscular dystrophy, the overwhelming majority of patients are male.<xref ref-type="bibr" rid="article-25401.r4">[4]</xref>&#x000a0;Symptomatic disease in daughters&#x000a0;can be&#x000a0;explained by factors such as Turner syndrome, skewed X chromosome inactivation, translocation of the mutated gene to an autosome, or uniparental disomy (both copies of a chromosome set originating from one parent).<xref ref-type="bibr" rid="article-25401.r80">[80]</xref>&#x000a0;Typically, symptomatic females present in infancy with proximal muscle weakness.<xref ref-type="bibr" rid="article-25401.r81">[81]</xref>&#x000a0;Reports exist of increased weakness in adulthood, myalgias, spasms, and lethargy as initial manifestations.<xref ref-type="bibr" rid="article-25401.r75">[75]</xref>&#x000a0;Scoliosis and sustained alveolar hypoventilation can cause severe problems for every child with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r82">[82]</xref></p>
        <p>
<bold>Cardiovascular Findings</bold>
</p>
        <p>
<bold>Arrhythmias</bold>
</p>
        <p>Cardiac arrhythmias have&#x000a0;greater&#x000a0;significance in individuals&#x000a0;with muscular dystrophy. The typical electrocardiogram (ECG) shows increased net RS in lead V1, deep and narrow Q waves&#x000a0;in the precordial leads,&#x000a0;and tall right precordial R waves in V1.<xref ref-type="bibr" rid="article-25401.r83">[83]</xref>&#x000a0;Cardiac disturbances&#x000a0;are commonly observed in patients with Duchenne muscular dystrophy type 1.<xref ref-type="bibr" rid="article-25401.r84">[84]</xref>&#x000a0;</p>
        <p>Myotonic dystrophy also affects the heart muscle, causing arrhythmias and heart block.<xref ref-type="bibr" rid="article-25401.r85">[85]</xref>&#x000a0;ECG abnormalities include first-degree heart block and more extensive conduction system involvement. A complete heart block and sudden death can occur.<xref ref-type="bibr" rid="article-25401.r86">[86]</xref></p>
        <p>
<bold>Congestive heart failure</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Congestive heart failure&#x000a0;is rare in muscular dystrophy, typically occurring only in cases of severe stress, such as pneumonia.<xref ref-type="bibr" rid="article-25401.r87">[87]</xref>&#x000a0;Infrequent instances of congestive heart failure may result from cor pulmonale secondary to respiratory failure.<xref ref-type="bibr" rid="article-25401.r88">[88]</xref>&#x000a0;Additionally, mitral valve prolapse&#x000a0;is a common occurrence in individuals with&#x000a0;muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r88">[88]</xref></p>
        <p>
<bold>Dilated c</bold>
<bold>ardiomyopathy</bold>
</p>
        <p>Genetic dilated cardiomyopathies, accounting for 30% to 40% of nonischemic dilated cardiomyopathies, are associated with some cases of muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r89">[89]</xref>&#x000a0;In the skeletal myopathies, an ECG will reveal a dominant R wave in lead V1&#x000a0;(indicative of prominent posterior wall involvement).<xref ref-type="bibr" rid="article-25401.r90">[90]</xref>&#x000a0;While the presence of cardiomyopathy is prevalent in almost all patients with muscular dystrophy, a cardiac cause of death is not always certain.<xref ref-type="bibr" rid="article-25401.r91">[91]</xref>&#x000a0;The incidence of cardiac involvement in Duchenne muscular dystrophy is as high as 95%.<xref ref-type="bibr" rid="article-25401.r92">[92]</xref>&#x000a0;Chronic heart failure may occur in 50% of children.<xref ref-type="bibr" rid="article-25401.r93">[93]</xref></p>
        <p>
<bold>Musculoskeletal Findings</bold>
</p>
        <p>Research findings&#x000a0;suggest that the&#x000a0;gracilis, semimembranosus, semitendinosus, and sartorius muscles can be&#x000a0;affected in patients with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r94">[94]</xref>&#x000a0;Additionally, individuals may&#x000a0;exhibit an equinovarus feet deformity,<xref ref-type="bibr" rid="article-25401.r95">[95]</xref>&#x000a0;pelvic tilting,<xref ref-type="bibr" rid="article-25401.r73">[73]</xref>&#x000a0;and contractures throughout the body.<xref ref-type="bibr" rid="article-25401.r96">[96]</xref>&#x000a0;Furthermore, spinal deformities may&#x000a0;lead to conditions such as&#x000a0;lordosis or scoliosis,<xref ref-type="bibr" rid="article-25401.r97">[97]</xref>&#x000a0;and&#x000a0;ocular issues like&#x000a0;cataracts and bilateral ptosis can also occur.<xref ref-type="bibr" rid="article-25401.r98">[98]</xref></p>
        <p>
<bold>Contractures</bold>
</p>
        <p>Most patients&#x000a0;with muscular dystrophy experience joint contractures of varying degrees, affecting the elbows, hips, knees, and ankles.&#x000a0;Arthrogryposis, or joint contractures present at birth, can occur.&#x000a0;Contractures of the heel cords and iliotibial bands manifest by age&#x000a0;6, accompanied by&#x000a0;toe walking&#x000a0;and a lordotic posture. Prolonged sitting worsens joint contractures, particularly in the hips, knees, elbows, and wrists.<xref ref-type="bibr" rid="article-25401.r99">[99]</xref>&#x000a0;Contractures become fixed, contributing to muscular atrophy, skeletal deformities, and the development of progressive scoliosis often associated with pain.<xref ref-type="bibr" rid="article-25401.r3">[3]</xref><xref ref-type="bibr" rid="article-25401.r99">[99]</xref>&#x000a0;</p>
        <p>Duchenne muscular dystrophy leads to complications such as muscle weakness, contractures of the knees, hips, and other joints, and scoliosis.<xref ref-type="bibr" rid="article-25401.r100">[100]</xref>&#x000a0;The contractures and skeletal deformities that develop from facioscapulohumeral muscular dystrophy are less&#x000a0;frequent and less prominent than Duchenne muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r101">[101]</xref>&#x000a0;Clinical findings like foot drop and depressed or absent muscle stretch reflexes may be present.<xref ref-type="bibr" rid="article-25401.r102">[102]</xref></p>
        <p>
<bold>Delayed motor milestones</bold>
</p>
        <p>Duchenne muscular dystrophy is usually&#x000a0;diagnosed in children at&#x000a0;around the age of 3&#x000a0;when parents&#x000a0;observe&#x000a0;slow motor development.<xref ref-type="bibr" rid="article-25401.r103">[103]</xref>&#x000a0;Clinical symptoms&#x000a0;commonly&#x000a0;emerge between 5 and 15 years, marked by developmental delays in sitting, standing, and walking.<xref ref-type="bibr" rid="article-25401.r103">[103]</xref>&#x000a0;Children affected by Duchenne muscular dystrophy often exhibit clumsiness, frequent falls, and difficulties climbing stairs.<xref ref-type="bibr" rid="article-25401.r103">[103]</xref>&#x000a0;In contrast, individuals with Becker muscular dystrophy remain ambulatory into their teens and early 20s, with the average age for wheelchair necessity reported as 25 in one study.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0;The key distinction is that patients with Becker dystrophy can walk beyond age 15,&#x000a0;while&#x000a0;those with Duchenne dystrophy typically use a wheelchair by age 12.<xref ref-type="bibr" rid="article-25401.r103">[103]</xref></p>
        <p><bold>Expressionless facies</bold>&#x000a0;</p>
        <p>A characteristic feature noted from early childhood is the inability to close the eyes fully. The expression on the face is often described as expressionless, and the weakening of facial muscles results in a "drooping expression."&#x000a0;In myotonic dystrophy, the face&#x000a0;takes on a hatchet-shaped appearance due to facial wasting and weakness,&#x000a0;accompanied&#x000a0;by bilateral partial ptosis.&#x000a0;While bilateral facial palsy is rare, it is&#x000a0;crucial to rule out other possible diagnoses for facial weakness, including upper and lower motor neuron&#x000a0;disorders,&#x000a0;through thorough diagnostic tests.<xref ref-type="bibr" rid="article-25401.r104">[104]</xref></p>
        <p>
<bold>Fractures</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Muscle weakness and inactivity, particularly&#x000a0;in individuals&#x000a0;using a wheelchair full time,&#x000a0;contribute to the development of&#x000a0;osteoporosis and an increased risk of pathologic fractures. Bisphosphonates may&#x000a0;be considered to enhance bone strength in cases of fractures, although there&#x000a0;is a lack of&#x000a0;long-term studies on the safety of bisphosphonates in this population.<xref ref-type="bibr" rid="article-25401.r105">[105]</xref></p>
        <p>
<bold>Gait instability</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>The&#x000a0;affected individuals, particularly boys, frequently&#x000a0;stumble and&#x000a0;struggle&#x000a0;to keep pace with&#x000a0;peers&#x000a0;during play. In&#x000a0;pediatric disease, parents&#x000a0;may&#x000a0;notice&#x000a0;clumsiness or&#x000a0;rapid weakness in their child.<xref ref-type="bibr" rid="article-25401.r106">[106]</xref>&#x000a0;Activities such as running, jumping, and hopping&#x000a0;typically demonstrate&#x000a0;abnormalities.<xref ref-type="bibr" rid="article-25401.r107">[107]</xref></p>
        <p>
<bold>Gower sign</bold>
</p>
        <p>This clinical sign can be&#x000a0;elicited by&#x000a0;instructing the child to stand from a sitting position.<xref ref-type="bibr" rid="article-25401.r108">[108]</xref>&#x000a0;Children with muscular dystrophy and other&#x000a0;conditions with muscle wasting&#x000a0;lack the necessary muscle strength to stand.<xref ref-type="bibr" rid="article-25401.r108">[108]</xref>&#x000a0;Instead, they may adopt a prone position, thrust themselves onto all fours, and&#x000a0;subsequently "walk" their hands along their thighs to achieve a standing posture.<xref ref-type="bibr" rid="article-25401.r109">[109]</xref><xref ref-type="bibr" rid="article-25401.r108">[108]</xref>&#x000a0;A Gower sign&#x000a0;indicates significant proximal muscle weakness, particularly the lumbar and gluteal muscles.<xref ref-type="bibr" rid="article-25401.r108">[108]</xref>&#x000a0;</p>
        <p>
<bold>Muscle wasting</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Muscular weakness&#x000a0;typically begins in the pelvic girdle, causing a "waddling" gait. <xref ref-type="bibr" rid="article-25401.r103">[103]</xref>&#x000a0;About 80% of cases exhibit calf muscle hypertrophy.<xref ref-type="bibr" rid="article-25401.r110">[110]</xref>&#x000a0;The pattern of muscle wasting&#x000a0;observed in Becker muscular dystrophy&#x000a0;closely mirrors&#x000a0;that of Duchenne disease, with prominent involvement of proximal muscles, particularly&#x000a0;in the lower extremities.&#x000a0;As the&#x000a0;condition&#x000a0;advances, weakness becomes more widespread.<xref ref-type="bibr" rid="article-25401.r111">[111]</xref>&#x000a0;In Duchenne muscular dystrophy, the&#x000a0;weakening progresses over the following years, resulting in the loss of ambulation&#x000a0;by 8 to 13.</p>
        <p>
<bold>Myotonia</bold>
</p>
        <p>Myotonia is a prolonged&#x000a0;involuntary muscle contraction characterized by a delay in releasing grip during activities such as handshaking or closing the fist.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0; This phenomenon is typically evident around age 5 and can be observed through percussion of the thenar eminence, jaw, and forearm musculature. Forced voluntary closures reveal slow relaxation indicative of myotonia.&#x000a0;As&#x000a0;muscle deterioration progresses, the detection of myotonia becomes more challenging. Individuals with myotonic dystrophy may struggle to relax their grip, especially in colder conditions.<xref ref-type="bibr" rid="article-25401.r105">[105]</xref><xref ref-type="bibr" rid="article-25401.r112">[112]</xref>&#x000a0;</p>
        <p>
<bold>Pseudohypertrophy</bold>
</p>
        <p>Muscle pseudohypertrophy&#x000a0;in muscular dystrophy can&#x000a0;extend to the toes, with boys often presenting in preschool with signs such as muscle weakness, difficulty walking, and visibly enlarged calves.<xref ref-type="bibr" rid="article-25401.r113">[113]</xref><xref ref-type="bibr" rid="article-25401.r114">[114]</xref>&#x000a0; Despite the apparent size increase, the muscle itself is diminished. Calf hypertrophy can also be observed in congenital muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r115">[115]</xref></p>
        <p>
<bold>Proximal muscle weakness</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Proximal muscle weakness&#x000a0;is evident, particularly when contrasted with distal weakness in many listed conditions.<xref ref-type="bibr" rid="article-25401.r116">[116]</xref>&#x000a0;Specific evaluations, such as rising from a low seat or a squatting posture, are required to assess this aspect.<xref ref-type="bibr" rid="article-25401.r3">[3]</xref>&#x000a0;</p>
        <p>In Duchenne muscular dystrophy, muscles of the shoulder girdle are affected in 3 to 5 years, leading to bilateral sternocleidomastoid and trapezius involvement, myalgias without weakness, winging of the scapula, continuous muscle fiber loss resulting in weakness principally of the voluntary muscles of proximal upper and lower extremities. Congenital dystrophy forms may present with hypotonia&#x000a0;and proximal or generalized muscle weakness.&#x000a0;Loss of muscle strength is progressive, with more severe leg involvement than arm involvement. By&#x000a0;8&#x000a0;to 10 years of age, walking may&#x000a0;necessitate braces. Clinical instability originates in the pelvic girdle,&#x000a0;causing difficulty in standing from the floor (Gower sign),&#x000a0;climbing stairs, and a waddling gait&#x000a0;due to weakness in the lumbar and gluteal muscles.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0;</p>
        <p>Facioscapulohumeral muscular dystrophy begins with weakness and atrophy of facial and shoulder girdle (scapulohumeral) muscles.<xref ref-type="bibr" rid="article-25401.r117">[117]</xref>&#x000a0;Limb-girdle muscular dystrophy diagnosis is confirmed by excluding&#x000a0;acute events causing proximal weakness, and the clinical picture, including genetic pattern, excludes Duchenne and facioscapulohumeral muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r117">[117]</xref>&#x000a0;</p>
        <p>Early compromise of neck muscles, including flexors, sternocleidomastoids, and distal limb muscles, is&#x000a0;observed&#x000a0;in myotonic dystrophy.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0;Wrist extensors, finger extensors, and intrinsic hand muscle weakness impair function in myotonic dystrophy.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0;Ankle dorsiflexor weakness may induce a foot drop.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref>&#x000a0;Proximal muscles, however, continue&#x000a0;to become more powerful throughout myotonic dystrophy.&#x000a0;</p>
        <p>Scapuloperoneal muscular dystrophy, a variant of facioscapulohumeral muscular dystrophy, is different in that distal muscles in the lower extremity are involved early&#x000a0;rather than the early sign of&#x000a0;facial and shoulder muscle weakness seen in facioscapulohumeral dystrophy.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref></p>
        <p>
<bold>Scoliosis</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Once scoliosis begins, it is relentlessly progressive.&#x000a0;Curves of more than 20&#x000b0; require surgical intervention to maintain pulmonary function.<xref ref-type="bibr" rid="article-25401.r118">[118]</xref></p>
        <p>
<bold>Toe walking</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>The foot assumes an equinovarus position, and the child tends to walk on the toes because of the weakness of the anterior tibial and peroneal muscles.<xref ref-type="bibr" rid="article-25401.r119">[119]</xref>&#x000a0;Patients with muscular dystrophy often toe-walk because of the weakness of the anterior tibial and peroneal muscles, causing the feet to assume a talipes equinovarus position.<xref ref-type="bibr" rid="article-25401.r120">[120]</xref>&#x000a0;</p>
        <p>
<bold>Neurological Findings</bold>
</p>
        <p>
<bold>Cognitive dysfunction</bold>
</p>
        <p>Mild to moderate cognitive&#x000a0;impairment&#x000a0;are common but not universal.<xref ref-type="bibr" rid="article-25401.r121">[121]</xref>&#x000a0;Intellectual impairment in Duchenne dystrophy is common, with the average intelligence quotient (IQ) approximately&#x000a0;1 standard deviation below the mean.<xref ref-type="bibr" rid="article-25401.r122">[122]</xref>&#x000a0;A moderate degree of intellectual disability causes these children to have a mean IQ of approximately 80.<xref ref-type="bibr" rid="article-25401.r123">[123]</xref>&#x000a0;Impairment of intellectual function appears nonprogressive, affecting verbal ability more than performance.<xref ref-type="bibr" rid="article-25401.r124">[124]</xref>&#x000a0;Mental retardation may occur in Becker dystrophy, but it is not as common as in Duchenne.&#x000a0;The central nervous system&#x000a0;is affected by some forms of congenital muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r121">[121]</xref><xref ref-type="bibr" rid="article-25401.r125">[125]</xref></p>
        <p>
<bold>Seizures and hypersomnia</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>The excessive urge to sleep and daytime sleepiness are common.<xref ref-type="bibr" rid="article-25401.r126">[126]</xref>&#x000a0;These sleep-related issues in individuals with muscular dystrophy may contribute to overall fatigue and impact daily functioning.&#x000a0;In merosin and FKRP deficiency associated with muscular dystrophy, the occurrence of mental retardation and seizures is observed in only a minority of patients.<xref ref-type="bibr" rid="article-25401.r127">[127]</xref></p>
        <p><bold>Visual disturbances</bold>&#x000a0;</p>
        <p>Myotonic dystrophy may manifest as ptosis, resulting in impaired vision and contributing to the characteristic clinical presentation of the condition.<xref ref-type="bibr" rid="article-25401.r128">[128]</xref><xref ref-type="bibr" rid="article-25401.r129">[129]</xref>&#x000a0;Moreover, individuals with myotonic dystrophy may experience double vision (diplopia) and other visual disturbances due to the involvement of eye muscles, further impacting their ocular function.</p>
        <p>
<bold>Respiratory Findings</bold>
</p>
        <p>
<bold>Chest deformity</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>The presence of scoliosis-related chest deformity further compromises pulmonary function, exacerbating&#x000a0;the respiratory challenges already imposed by&#x000a0;muscle weakness in individuals with myotonic dystrophy.<xref ref-type="bibr" rid="article-25401.r130">[130]</xref>&#x000a0;Additionally, it is essential to conduct examinations for gynecomastia,&#x000a0;as this condition can coexist in patients with&#x000a0;myotonic dystrophy.&#x000a0;</p>
        <p>
<bold>Recurrent pulmonary infections</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Around the age of 16&#x000a0;to 18,&#x000a0;individuals affected by muscular dystrophy become increasingly vulnerable to severe and potentially fatal&#x000a0;pulmonary infections.<xref ref-type="bibr" rid="article-25401.r131">[131]</xref>&#x000a0;The heightened susceptibility to respiratory tract infections, coupled with the progressive deterioration of pulmonary function, typically results in premature mortality,&#x000a0;often occurring in the 20s.<xref ref-type="bibr" rid="article-25401.r132">[132]</xref></p>
        <p>
<bold>Respiratory insufficiency</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Respiratory failure is the most common cause of death in individuals with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r82">[82]</xref>&#x000a0;Careful inspection reveals areas of muscle wasting.&#x000a0;An urgent comprehensive assessment is crucial for patients exhibiting sudden-onset muscle weakness, as respiratory muscle involvement&#x000a0;can progress&#x000a0;to respiratory failure.<xref ref-type="bibr" rid="article-25401.r133">[133]</xref>&#x000a0;Diaphragm and intercostal muscle weakness may contribute to respiratory insufficiency in some cases.<xref ref-type="bibr" rid="article-25401.r39">[39]</xref>&#x000a0;</p>
        <p>The disease often follows a progressive course&#x000a0;with subsequent&#x000a0;respiratory complications potentially culminating in respiratory failure.&#x000a0;The development of&#x000a0;marked kyphoscoliosis further compromises pulmonary function, especially as children transition to wheelchair use. With advancing age, escalating muscle weakness and&#x000a0;respiratory involvement result in&#x000a0;breathing difficulties, particularly&#x000a0;during sleeping.<xref ref-type="bibr" rid="article-25401.r134">[134]</xref></p>
        <p>
<bold>Sleep apnea</bold>
</p>
        <p>Individuals with muscular dystrophy commonly experience an increased need or desire for sleep, often accompanied by diminished motivation.<xref ref-type="bibr" rid="article-25401.r135">[135]</xref>&#x000a0;Continuous monitoring and appropriate interventions are crucial to manage sleep apnea in this population and improve overall respiratory health.</p>
        <p>
<bold>Other Findings</bold>
</p>
        <p>Individuals with certain forms of muscular dystrophy may experience challenges with bladder control, leading to symptoms such as urinary urgency.<xref ref-type="bibr" rid="article-25401.r136">[136]</xref>&#x000a0;Moreover, an eye exam may&#x000a0;reveal iridescent spots, potentially indicating an underlying dystrophy.<xref ref-type="bibr" rid="article-25401.r137">[137]</xref><xref ref-type="bibr" rid="article-25401.r138">[138]</xref>&#x000a0;Esophageal muscles can also be involved, causing dysphagia.<xref ref-type="bibr" rid="article-25401.r75">[75]</xref>&#x000a0;</p>
        <p>Gonadal atrophy is associated with myotonic dystrophy.<xref ref-type="bibr" rid="article-25401.r47">[47]</xref><xref ref-type="bibr" rid="article-25401.r139">[139]</xref>&#x000a0;Upon physical examination, small soft testes may be noted, as well as hair loss.<xref ref-type="bibr" rid="article-25401.r47">[47]</xref>&#x000a0;Older individuals may have concerns of impotence likely caused by gonadal atrophy.<xref ref-type="bibr" rid="article-25401.r140">[140]</xref></p>
        <p>
<bold>Generalized digestive complaints</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Smooth muscle dysfunction associated with certain forms of muscular dystrophy may contribute to conditions such as megacolon, volvulus, cramping pain, and malabsorption in the gastrointestinal tract.<xref ref-type="bibr" rid="article-25401.r141">[141]</xref>&#x000a0;This dysfunction manifests as disturbed gastrointestinal peristalsis, decreasing esophageal and colonic motility.<xref ref-type="bibr" rid="article-25401.r142">[142]</xref>&#x000a0;Commonly, bowel functions are often mildly affected, presenting with constipation as a frequent symptom.<xref ref-type="bibr" rid="article-25401.r143">[143]</xref>&#x000a0;Severe complications, such as aspiration of food&#x000a0;and acute gastric dilation, may contribute to causes of death. Furthermore, palatal, pharyngeal, and tongue involvement can result in&#x000a0;dysarthric speech, nasal voice, and swallowing problems.<xref ref-type="bibr" rid="article-25401.r144">[144]</xref><xref ref-type="bibr" rid="article-25401.r145">[145]</xref></p>
        <p>
<bold>Insulin resistance</bold>
<italic toggle="yes">&#x000a0;</italic>
</p>
        <p>Individuals with muscular dystrophy may encounter challenges related to glucose metabolism, contributing to the increased prevalence of diabetes in this population.<xref ref-type="bibr" rid="article-25401.r146">[146]</xref>&#x000a0;This association underscores the importance of regularly monitoring and managing glucose levels in individuals with muscular dystrophy to address potential complications and optimize overall health.</p>
      </sec>
      <sec id="article-25401.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The choice of specific tests&#x000a0;depends&#x000a0;on the patient's symptoms, medical history, and suspected muscular dystrophy type. A comprehensive approach involving a combination of tests is often required to establish a definitive diagnosis and formulate an effective treatment strategy.</p>
        <p>
<bold>Laboratory Tests</bold>
</p>
        <p>Liver Enzymes</p>
        <list list-type="bullet">
          <list-item>
            <p>Alanine transaminase (ALT),&#x000a0;Aspartate aminotransferase (AST)</p>
          </list-item>
          <list-item>
            <p>Elevated levels are observed in muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r79">[79]</xref></p>
          </list-item>
        </list>
        <p>Aldolase:<italic toggle="yes">&#x000a0;</italic>Elevated levels are observed in muscular dystrophy, with a subsequent decrease in later stages.<xref ref-type="bibr" rid="article-25401.r147">[147]</xref></p>
        <p>Arterial blood gases: Respiratory acidosis can develop in the presence of defects in muscles involved in respiration, which can occur in muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r148">[148]</xref></p>
        <p>Creatine&#x000a0;phosphokinase</p>
        <list list-type="bullet">
          <list-item>
            <p>Creatinine phosphokinase or creatinine kinase (CK, CPK) and creatine kinase isoenzymes (CK-MB&#x000a0;and CK-MM)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Elevated levels&#x000a0;are observed in muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r149">[149]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The serum enzymes, especially CPK, are increased to more than&#x000a0;10 times normal, even in infancy and before the onset of weakness.<xref ref-type="bibr" rid="article-25401.r150">[150]</xref>&#x000a0;Diagnosis is suggested (a high&#x000a0;CPK level does not confirm the diagnosis because many other alterations can also increase CPK) by measuring the blood CPK level, which can be 100 times the normal level, with diagnostic confirmation by genetic testing for mutations in the dystrophin gene.<xref ref-type="bibr" rid="article-25401.r151">[151]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Serum CPK levels are invariably elevated between 20 and 100 times normal in Duchenne muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r152">[152]</xref>&#x000a0;The levels are abnormal at birth, but values decline late in the disease because of inactivity and loss of muscle mass.<xref ref-type="bibr" rid="article-25401.r153">[153]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Elevated CPK levels at birth are diagnostic indicators of Duchenne muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r154">[154]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Identifying female carriers of the&#x000a0;condition is not achievable with certainty, but serum CPK is elevated in 60% to 80% of carriers.<xref ref-type="bibr" rid="article-25401.r155">[155]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Serum CPK can be 2 to 20 times above normal in Emery-Dreifuss muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r156">[156]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Myotonic dystrophy may be associated with a normal CPK or only mild elevation.<xref ref-type="bibr" rid="article-25401.r84">[84]</xref></p>
          </list-item>
        </list>
        <p>Lactate dehydrogenase:<bold><italic toggle="yes">&#x000a0;</italic></bold>Elevated in muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r147">[147]</xref></p>
        <p>Urinalysis:<bold><italic toggle="yes">&#x000a0;</italic></bold>Findings in individuals with muscular dystrophy often reveal the presence of glucose in the urine, which can be attributed to the elevated prevalence of diabetes mellitus within this population.<xref ref-type="bibr" rid="article-25401.r157">[157]</xref>&#x000a0;Myoglobinuria may also&#x000a0;be detected.<xref ref-type="bibr" rid="article-25401.r147">[147]</xref></p>
        <p>
<bold>Radiographic Tests</bold>
</p>
        <p>Magnetic resonance imaging:</p>
        <list list-type="bullet">
          <list-item>
            <p>Coronal T1 weighted magnetic resonance imaging (MRI)&#x000a0;is a valuable diagnostic tool to confirm the&#x000a0;nonuniform fatty atrophy associated with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r158">[158]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A&#x000a0;relatively normal sartorius can be observed.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lateral radiographs may&#x000a0;reveal a cavus foot deformity and diffuse osteopenia.<xref ref-type="bibr" rid="article-25401.r159">[159]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The sagittal view&#x000a0;can show diffuse fat replacement of the gastrocnemius &#x00026; semimembranosus muscles.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>These structural changes contribute to the&#x000a0;characteristic prominence of calves&#x000a0;often observed&#x000a0;in affected children.<xref ref-type="bibr" rid="article-25401.r114">[114]</xref></p>
          </list-item>
        </list>
        <p>Computerized tomography:&#x000a0;Axial computerized tomography (CT)&#x000a0;reveals denervation hypertrophy of the tensor fascia lata. This muscle&#x000a0;exhibits enlargement accompanied by an increase in intramuscular fat.<xref ref-type="bibr" rid="article-25401.r160">[160]</xref></p>
        <p>
<bold>Other Tests</bold>
</p>
        <p>Chromosomal analysis:</p>
        <list list-type="bullet">
          <list-item>
            <p>The DNA deletion size does not predict clinical severity in Becker and Duchenne dystrophies.<xref ref-type="bibr" rid="article-25401.r161">[161]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In approximately 95% of Becker dystrophy cases, "in-frame" mutations, despite the DNA deletion, maintain the translational read frame of messenger RNA.&#x000a0;This preservation enables the development of dystrophin, as evident in the presence of dystrophin on Western blot examination.<xref ref-type="bibr" rid="article-25401.r162">[162]</xref></p>
          </list-item>
        </list>
        <p>Electrocardiogram:</p>
        <list list-type="bullet">
          <list-item>
            <p>Often, patients will have annual electrocardiograms (ECGs) as a proactive measure to monitor the potential development of cardiomyopathy.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>This diagnostic study reveals atrial and atrioventricular rhythm disturbances.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The typical&#x000a0;ECG findings&#x000a0;include an increased net RS in lead V1, deep, narrow Q waves in the precordial leads, and&#x000a0;A&#x000a0;QRS complex&#x000a0;too narrow to be right bundle branch block; and tall right precordial R waves in V1.<xref ref-type="bibr" rid="article-25401.r163">[163]</xref><xref ref-type="bibr" rid="article-25401.r164">[164]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The dominant R wave in lead V1&#x000a0;is a crucial&#x000a0;clue&#x000a0;for&#x000a0;an&#x000a0;accurate&#x000a0;diagnosis.<xref ref-type="bibr" rid="article-25401.r165">[165]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>There are abnormal Q waves in the precordial leads.&#x000a0;Prominent Q waves in lead II.<xref ref-type="bibr" rid="article-25401.r166">[166]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>QRS axis shows deviation.<xref ref-type="bibr" rid="article-25401.r167">[167]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Significant ECG irregularities and the diagnosis of atrial tachyarrhythmia are&#x000a0;indicative of the risk of sudden death.<xref ref-type="bibr" rid="article-25401.r168">[168]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A P wave with a&#x000a0;prominent early deflection in lead V1&#x000a0;reflects right atrial enlargement.<xref ref-type="bibr" rid="article-25401.r166">[166]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>The ECG could mimic pulmonary hypertension, primarily observed in lead V1 with&#x000a0;QRS right axis deviation.<xref ref-type="bibr" rid="article-25401.r166">[166]</xref>&#x000a0;While less likely, an old true posterior wall myocardial infarction could be considered. However, looking for an associated inferior wall myocardial infarction, which will be absent&#x000a0;in cases associated with dystrophinopathies, is essential.<xref ref-type="bibr" rid="article-25401.r90">[90]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>A progressively lengthening PR interval and QRS duration indicate the increasing severity of conduction disease.<xref ref-type="bibr" rid="article-25401.r169">[169]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>An implantable cardioverter-defibrillator should be considered&#x000a0;for all patients.<xref ref-type="bibr" rid="article-25401.r86">[86]</xref></p>
          </list-item>
        </list>
        <p>Electromyography:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Electromyography (EMG) reveals characteristic features of myopathy during the assessment.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Enables evaluation&#x000a0;of muscle denervation, myopathies, myotonic dystrophy, and motor neuron disease.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>EMG demonstrates features typical of myopathy.<xref ref-type="bibr" rid="article-25401.r170">[170]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In clinical examination and EMG, changes are&#x000a0;detectable in nearly any muscle, marked by the waxing and waning of potentials termed the "dive bomber effect."<xref ref-type="bibr" rid="article-25401.r171">[171]</xref></p>
          </list-item>
        </list>
        <p>Genetic testing:</p>
        <list list-type="bullet">
          <list-item>
            <p>A definitive diagnosis of muscular dystrophy can be established&#x000a0;through mutation analysis performed on peripheral blood leukocytes.<xref ref-type="bibr" rid="article-25401.r172">[172]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Genetic testing&#x000a0;reveals deletions or duplications of the dystrophin gene in 65% of patients with Becker dystrophy,&#x000a0;a proportion similar to&#x000a0;Duchenne dystrophy.<xref ref-type="bibr" rid="article-25401.r173">[173]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Multiplex polymerase chain reaction (PCR) is commonly employed to detect deletions, while sequencing is utilized to identify other mutations.<xref ref-type="bibr" rid="article-25401.r174">[174]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Carrier females&#x000a0;can be determined&#x000a0;through mutation testing or by linkage to intragenic markers, allowing for an intragenic recombination rate of 12%.<xref ref-type="bibr" rid="article-25401.r175">[175]</xref></p>
          </list-item>
        </list>
        <p>Immunocytochemistry:<bold><italic toggle="yes">&#x000a0;</italic></bold></p>
        <list list-type="bullet">
          <list-item>
            <p>A definitive diagnosis of muscular dystrophy&#x000a0;relies on identifying&#x000a0;dystrophin deficiency in a muscle tissue biopsy.<xref ref-type="bibr" rid="article-25401.r176">[176]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Staining muscle with dystrophin antibodies can demonstrate the absence or deficiency of dystrophin localizing to the sarcolemmal membrane.<xref ref-type="bibr" rid="article-25401.r1">[1]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Disease carriers&#x000a0;exhibit&#x000a0;a mosaic pattern, but dystrophin analysis&#x000a0;in muscle biopsy specimens&#x000a0;is not a reliable method for carrier detection.<xref ref-type="bibr" rid="article-25401.r177">[177]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Immunohistochemistry&#x000a0;also reveals&#x000a0;the absence of emerin staining of myonuclei in X-linked Emery-Dreifuss due to emerin mutations.<xref ref-type="bibr" rid="article-25401.r178">[178]</xref></p>
          </list-item>
        </list>
        <p>Muscle biopsy</p>
        <list list-type="bullet">
          <list-item>
            <p>The muscle biopsy&#x000a0;reveals varying muscle fiber sizes and small groups of necrotic and regenerating fibers.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lost muscle fibers are replaced by connective tissue and fat.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Muscle biopsy usually shows nonspecific dystrophic features, although cases associated with FHL1 mutations have features of myofibrillar myopathy.<xref ref-type="bibr" rid="article-25401.r179">[179]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In 50% of cases, muscle biopsy shows muscle atrophy&#x000a0;selectively involving Type 1 fibers.<xref ref-type="bibr" rid="article-25401.r75">[75]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Various agentic nuclei can be observed in muscle cells as well as in dysplastic fibers with intracytoplasmic nuclear clusters.<xref ref-type="bibr" rid="article-25401.r180">[180]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Histologic changes in muscle include degeneration of muscle fibers,&#x000a0;featuring variation in fiber size and the presence of central nuclei.<xref ref-type="bibr" rid="article-25401.r181">[181]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In scapuloperoneal muscular dystrophy, fiber splitting is observed, and fibers appear profusely "moth-eaten" and whorled.<xref ref-type="bibr" rid="article-25401.r182">[182]</xref></p>
          </list-item>
        </list>
        <p>Polysomnogram: Excessive daytime sleepiness with or without sleep apnea is common. Sleep studies, noninvasive respiratory support (biphasic positive airway pressure [BiPAP]), and treatment with modafinil may be beneficial.<xref ref-type="bibr" rid="article-25401.r183">[183]</xref></p>
        <p>Pulmonary function tests: Assessing lung function with a pulmonary function test (PFT) is valuable in evaluating the impact of muscular dystrophy on respiratory capabilities.</p>
        <p>Slit Lamp:&#x000a0;An examination for cataracts that may be present in patients with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r184">[184]</xref></p>
        <p>Western blot:&#x000a0;Duchenne dystrophy can&#x000a0;be diagnosed through&#x000a0;Western blot analysis of muscle biopsy specimens, revealing abnormalities in dystrophin proteins' quantity and molecular weight. In Becker muscular dystrophy, dystrophin levels&#x000a0;may appear normal on Western blot despite the abnormal protein, contrasting with significantly decreased dystrophin levels in individuals with Duchenne muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r185">[185]</xref></p>
      </sec>
      <sec id="article-25401.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment for muscular dystrophy focuses on managing symptoms, slowing the progression of the disease, and improving the quality of life for affected individuals. While there is no cure for muscular dystrophy, various interventions aim to address specific challenges associated with muscle weakness, mobility issues, and potential complications. Physical therapy, assistive devices, medications, and, in some cases, surgical procedures may be part of a comprehensive treatment plan.</p>
        <p>
<bold>Pharmaceutical&#x000a0;Interventions</bold>
</p>
        <p>Antiarrhythmics play a pivotal role in managing cardiac complications associated with muscular dystrophy. For patients experiencing prevalent cardiac conduction issues, the use of angiotensin-converting enzyme (ACE) inhibitors and specific antiarrhythmic drugs is a common approach. In cases of atrial arrhythmias, preference is given to medications like flecainide, propafenone, and beta-blockers. Amiodarone is reserved for patients unresponsive to initial drugs, taking into account factors such as the patient's age, the need for long-term therapy, and the heightened risk of adverse effects on the thyroid and pulmonary function.<xref ref-type="bibr" rid="article-25401.r186">[186]</xref></p>
        <p>Myotonia, characterized by muscle rigidity and associated pain, can be effectively managed with sodium channel blockers such as phenytoin, procainamide, or mexiletine. Dosing for these medications is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Phenytoin 100 mg orally 3 times daily</p>
          </list-item>
          <list-item>
            <p>Procainamide 0.5 to 1 g orally 4 times daily</p>
          </list-item>
          <list-item>
            <p>Mexiletine 150 to 200 mg orally 3 times daily</p>
          </list-item>
        </list>
        <p>However, the associated side effects, particularly for antiarrhythmic medications, are often limiting.<xref ref-type="bibr" rid="article-25401.r187">[187]</xref>&#x000a0;Phenytoin and mexiletine are preferred for symptomatic patients requiring anti-myotonia medication, as other medications like quinine and procainamide may elevate the risk of cardiovascular complications.<xref ref-type="bibr" rid="article-25401.r188">[188]</xref></p>
        <p>Steroids, specifically glucocorticoids like prednisone, administered at a dose of 0.75 mg/kg per day, significantly slow the progression of muscular dystrophy for up to&#x000a0;3 years.<xref ref-type="bibr" rid="article-25401.r189">[189]</xref>&#x000a0; While some patients may not tolerate glucocorticoid therapy due to factors like weight gain and an increased risk of fractures, recent evidence suggests that early oral steroid use can lead to markedly improved outcomes.<xref ref-type="bibr" rid="article-25401.r190">[190]</xref><xref ref-type="bibr" rid="article-25401.r191">[191]</xref>&#x000a0;This includes additional walking years for children and increased life expectancy.<xref ref-type="bibr" rid="article-25401.r71">[71]</xref>&#x000a0;The use of glucocorticoids in Becker dystrophy and their effectiveness in treating myotonic muscular dystrophy remain areas where research is ongoing, and evidence is not yet conclusive.<xref ref-type="bibr" rid="article-25401.r192">[192]</xref><xref ref-type="bibr" rid="article-25401.r193">[193]</xref>&#x000a0;Some individuals with facioscapulohumeral muscular dystrophy improve with steroid therapy, particularly when rapidly progressive weakness is observed.<xref ref-type="bibr" rid="article-25401.r194">[194]</xref>&#x000a0;&#x000a0;</p>
        <p>Medications like antiepileptics and nonsteroidal anti-inflammatory drugs (NSAIDs) play a crucial role in treating symptoms due to muscular dystrophy.&#x000a0;Antiepileptics play a crucial role in effectively managing seizures in some individuals with muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r195">[195]</xref>&#x000a0;The use of NSAIDs is part of the treatment plan to reduce pain and inflammation.<xref ref-type="bibr" rid="article-25401.r196">[196]</xref></p>
        <p>Golodirsen&#x000a0;(SRP-4053),&#x000a0;an antisense therapy&#x000a0;designed to treat Duchenne muscular dystrophy, is approved by the Food and Drug Administration (FDA). However, the evidence supporting its use, particularly in cases requiring exon 53 skipping, is still evolving and not fully established.<xref ref-type="bibr" rid="article-25401.r197">[197]</xref><xref ref-type="bibr" rid="article-25401.r198">[198]</xref></p>
        <p>
<bold>Surgical Interventions</bold>
</p>
        <p>Various surgical interventions play a crucial role in managing muscular dystrophy, each tailored to address specific aspects of the condition. Contracture release, achieved through surgical means, is employed to maintain normal function for as long as possible.<xref ref-type="bibr" rid="article-25401.r199">[199]</xref>&#x000a0;Adjunct therapies like massage and heat treatments can complement this procedure.</p>
        <p>In cases where cardiac complications are evident, installing a defibrillator or cardiac pacemaker may be considered to monitor and manage cardiomyopathy and arrhythmias, potentially offering life-saving benefits.<xref ref-type="bibr" rid="article-25401.r86">[86]</xref>&#x000a0;Indications for cardiac pacemaker placement are as follows:<xref ref-type="bibr" rid="article-25401.r200">[200]</xref><xref ref-type="bibr" rid="article-25401.r201">[201]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Severe syncope</p>
          </list-item>
          <list-item>
            <p>Established conduction system disorders with a second-degree heart block</p>
          </list-item>
          <list-item>
            <p>Tri-fascicular conduction abnormalities with PR interval lengthening</p>
          </list-item>
          <list-item>
            <p>Advanced cardiac block</p>
          </list-item>
        </list>
        <p>For individuals with facioscapulohumeral muscular dystrophy, shoulder surgery might be beneficial to stabilize the shoulder.<xref ref-type="bibr" rid="article-25401.r202">[202]</xref>&#x000a0;When scoliotic curves exceed 20&#x000b0;, spinal correction through surgery can prolong respiratory function, walking ability, or both.<xref ref-type="bibr" rid="article-25401.r118">[118]</xref></p>
        <p>
<bold>Other Interventions</bold>
</p>
        <p>In addition to pharmacologic intervention,&#x000a0;comprehensive supportive care&#x000a0;measures are essential for managing muscular dystrophy. Supportive physiotherapy is crucial, focusing on preventing contractures and prolonging ambulation.<xref ref-type="bibr" rid="article-25401.r45">[45]</xref>&#x000a0;The primary goal is to maintain function in unaffected muscle groups, balancing activity to avoid the hastening of muscle fiber breakdown. Strenuous exercise is approached with caution, considering its potential impact.<xref ref-type="bibr" rid="article-25401.r203">[203]</xref></p>
        <p>Supportive bracing is implemented to maintain normal function as long as possible. Proper wheelchair seating is essential, and molded ankle-foot orthoses are vital, particularly in stabilizing the gait of those with foot drop.<xref ref-type="bibr" rid="article-25401.r204">[204]</xref> Lightweight plastic ankle-foot orthoses (AFOs) prove highly beneficial for treating footdrop, ensuring individuals with scapuloperoneal muscular dystrophy remain ambulatory for extended periods (&#x02265;40 years).<xref ref-type="bibr" rid="article-25401.r205">[205]</xref><xref ref-type="bibr" rid="article-25401.r206">[206]</xref>&#x000a0;Wheelchairs may be utilized for long-distance travel when necessary, and bracing is tailored for functional purposes, such as preventing tripping or offering support and comfort.<xref ref-type="bibr" rid="article-25401.r99">[99]</xref></p>
        <p>Supportive counseling is integral to addressing the psychosocial aspects of the condition. Some forms of muscular dystrophy may experience periods of arrest, allowing patients to remain active with an average life expectancy.<xref ref-type="bibr" rid="article-25401.r207">[207]</xref> Vocational training and supportive counseling are crucial in providing information for planning their future.</p>
        <p>Genetic counseling is recommended, especially for X-linked inheritance cases.<xref ref-type="bibr" rid="article-25401.r208">[208]</xref>&#x000a0;Male siblings have a 50% chance of being affected,&#x000a0;while female siblings have a 50% chance of being carriers. If the affected individual has children, all daughters will be carriers of this X-linked recessive disorder. Genetic counseling should be&#x000a0;extended to the mother, female siblings, offspring, and maternal relatives.</p>
        <p>While radiation therapy is not typically the primary treatment modality for muscular dystrophy, it may have a role in managing specific symptoms and complications associated with the disease. It is important to consider&#x000a0;radiation therapy as part of a multidisciplinary treatment plan and carefully evaluate each patient's individual needs and risks. Further research is needed to better understand the potential benefits and risks of radiation therapy in this patient population.</p>
      </sec>
      <sec id="article-25401.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Muscular dystrophy is not always a straightforward diagnosis and can be mistaken for several other diseases with overlapping etiologies. Clinicians must carefully consider and exclude the following conditions in patients presenting with a muscular disorder, as these alternative diagnoses can lead to significant morbidity and mortality:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>Electrolyte imbalance: sodium, potassium, and magnesium</p>
          </list-item>
          <list-item>
            <p>Hypercalcemia</p>
          </list-item>
          <list-item>
            <p>Porphyrias</p>
          </list-item>
          <list-item>
            <p>Rabies</p>
          </list-item>
          <list-item>
            <p>Complicated migraine</p>
          </list-item>
          <list-item>
            <p>Postictal (Todd) paralysis</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Acute spastic paraparesis (a medical emergency)</p>
          </list-item>
          <list-item>
            <p>Myasthenia gravis</p>
          </list-item>
          <list-item>
            <p>Pancoast tumor</p>
          </list-item>
          <list-item>
            <p>Paraneoplastic syndromes</p>
          </list-item>
        </list>
        <p>An acute onset gait disorder is&#x000a0;often indicative of&#x000a0;acute systemic decompensation. A thorough and systematic evaluation&#x000a0;is essential to exclude&#x000a0;catastrophic presentations. It&#x000a0;is not&#x000a0;recommended to attribute a gait disorder to&#x000a0;a single disease.&#x000a0;Gait abnormalities can indicate a severe medical emergency, especially when the problem is associated with any of these additional symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Headache (raised intracranial&#x000a0;pressure)</p>
          </list-item>
          <list-item>
            <p>Nausea or vomiting</p>
          </list-item>
          <list-item>
            <p>Decreased alertness</p>
          </list-item>
          <list-item>
            <p>Impaired coordination presenting on only one side of the body</p>
          </list-item>
          <list-item>
            <p>Recent viral illness/immunization (Guillain-Barr&#x000e9; syndrome)</p>
          </list-item>
          <list-item>
            <p>Trauma.</p>
          </list-item>
        </list>
        <p>Questions to consider when evaluating a patient:</p>
        <p><bold>Are reflexes hypoactive?</bold> Hypoactive reflexes&#x000a0;may suggest myotonic dystrophy, tabes dorsalis, and progressive muscular atrophy.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref> However, diminished reflexes can also be a result of weakness.</p>
        <p><bold>Is there any pain present?</bold>&#x000a0;Muscle&#x000a0;weakness and, occasionally, myalgia are typical features of muscle disease.&#x000a0;Conversely, a short history of painful weakness in adulthood would suggest an inflammatory myositis.<xref ref-type="bibr" rid="article-25401.r209">[209]</xref></p>
        <p><bold>Is the problem acute or chronic?&#x000a0;</bold>The age and rate of progression&#x000a0;can help determine the type of muscle disease.&#x000a0;Progressive slow weakness&#x000a0;without pain from childhood may indicate degenerative muscular dystrophy. Diseases like Dreifuss muscular dystrophy and Bethlem myopathy cause early fixed contractures, representing distinctive features.<xref ref-type="bibr" rid="article-25401.r3">[3]</xref></p>
        <p><bold>Is weakness primarily distal or proximal?</bold>&#x000a0;The distribution of weakness helps define&#x000a0;the likely type of muscle disease. Proximal arm and leg weakness may be present in limb-girdle muscular dystrophy.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref></p>
        <p><bold>Is the weakness localized or diffuse?&#x000a0;</bold>Muscle&#x000a0;weakness&#x000a0;could be attributed to various causes, including&#x000a0;myopathies (eg, dermatomyositis), inflammatory diseases (eg, rheumatoid arthritis), neurologic disorders (eg, Guillain-Barr&#x000e9; syndrome), or infections (eg, Lyme disease or trichinosis).<xref ref-type="bibr" rid="article-25401.r77">[77]</xref></p>
        <p><bold>Are there any focal neurological lesions?</bold>&#x000a0;Conditions like myotonic dystrophy, myasthenia gravis, and progressive muscular atrophy may present with partial ptosis.<xref ref-type="bibr" rid="article-25401.r77">[77]</xref></p>
      </sec>
      <sec id="article-25401.s11" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Radiation therapy (RT) has been studied as a potential treatment for muscular dystrophy, particularly in the context of Duchenne muscular dystrophy.</p>
        <p>One study published in the Journal of Radiation Research in 2018 evaluated the effects of low-dose whole-body irradiation in a mouse model of DMD. The study found that low-dose irradiation improved muscle strength and reduced muscle damage in the mice, suggesting that RT may have therapeutic potential in the treatment of DMD.</p>
        <p>Another study published in the journal Frontiers in Oncology in 2019 reviewed the available literature on the use of RT for muscular dystrophy. The authors found that while there is limited data on the effectiveness of RT for muscular dystrophy, early studies suggest that low-dose RT may be a promising treatment option. However, more research is needed to determine the optimal dose and timing of RT for this condition.</p>
        <p>Currently, there are no ongoing clinical trials specifically evaluating the use of RT for muscular dystrophy. However, there are ongoing trials exploring gene therapy and other novel approaches for the treatment of DMD, which may have implications for the use of RT in the future.</p>
      </sec>
      <sec id="article-25401.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Individuals&#x000a0;with dystrophies&#x000a0;involving&#x000a0;significant heart involvement may&#x000a0;still have&#x000a0;nearly average life spans,&#x000a0;given diligent&#x000a0;monitoring and aggressive treatment of cardiac issues.<xref ref-type="bibr" rid="article-25401.r90">[90]</xref>&#x000a0;Long-term care focuses on preserving ambulation and closely tracking any signs of cardiopulmonary complications.&#x000a0;Despite notable progress in muscular dystrophy treatment, the disease remains&#x000a0;incurable and&#x000a0;lacks preventative measures. Most patients succumb to cardiopulmonary failure before reaching 30.<xref ref-type="bibr" rid="article-25401.r210">[210]</xref> Proper care, however, can enhance the quality of life for affected individuals.</p>
        <p>Duchenne muscular dystrophy&#x000a0;typically results in a life expectancy of&#x000a0;around 20 years,&#x000a0;with a fatal outcome&#x000a0;in 100% of cases.<xref ref-type="bibr" rid="article-25401.r210">[210]</xref> Children&#x000a0;affected by Duchenne muscular dystrophy usually succumb to other pulmonary or cardiac causes,&#x000a0;with&#x000a0;death&#x000a0;occurring&#x000a0;in&#x000a0;the late teens. Only 25% live to age 21.<xref ref-type="bibr" rid="article-25401.r211">[211]</xref>&#x000a0;Walker-Warburg syndrome, the most severe congenital muscular dystrophy,&#x000a0;leads to death by&#x000a0;1 year of age.<xref ref-type="bibr" rid="article-25401.r211">[211]</xref>&#x000a0;Becker dystrophy is associated with a reduced life expectancy, but most individuals survive into the fourth or fifth decade.<xref ref-type="bibr" rid="article-25401.r211">[211]</xref>&#x000a0;Life expectancy is average in patients with facioscapulohumeral dystrophy.<xref ref-type="bibr" rid="article-25401.r211">[211]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25401.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Some complications of muscular dystrophy include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bone demineralization: Reduced mobilization and immobilization contribute to osteopenia and osteoporosis, leading to an increased risk of fractures and scoliosis.<xref ref-type="bibr" rid="article-25401.r212">[212]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cardiopulmonary disease: Regular monitoring is essential to address secondary complications such as cardiopulmonary disease or cardiac failure resulting from cardiomyopathy.<xref ref-type="bibr" rid="article-25401.r212">[212]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Disability: Muscular injuries and contractures can lead to disability, necessitating dependence on walking aids like wheelchairs.<xref ref-type="bibr" rid="article-25401.r212">[212]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Anesthesia Risk: Patients with muscular dystrophy may experience challenges with general anesthesia and typically require intensive postoperative observation for optimal care.<xref ref-type="bibr" rid="article-25401.r212">[212]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25401.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence and patient education for individuals with muscular dystrophy involves a comprehensive approach to prevent complications and enhance overall well-being. Key aspects include promoting appropriate physical activity, orthopedic care for scoliosis, cardiopulmonary monitoring, nutritional guidance, respiratory care, fall prevention strategies, genetic counseling, and medication management education.</p>
        <p>Emotional support through engagement with support groups and counseling services is also emphasized. Regular medical check-ups and open communication with healthcare providers are crucial in ongoing monitoring and addressing emerging concerns, allowing individuals to actively participate in their care and optimize their quality of life.</p>
      </sec>
      <sec id="article-25401.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about&#x000a0;muscular dystrophies&#x000a0;are&#x000a0;presented below.&#x000a0;</p>
        <p>
<bold>Duchenne muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Genetics:</bold> X-linked recessive disorder caused by mutations in the DMD gene.</p>
          </list-item>
          <list-item>
            <p><bold>Onset:</bold> Typically early childhood (around 3 to 5).</p>
          </list-item>
          <list-item>
            <p><bold>Clinical features:</bold> Progressive muscle weakness, particularly in the pelvic and shoulder girdle muscles.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic tests:</bold> Elevated&#x000a0;CK levels, genetic testing for DMD gene mutations.</p>
          </list-item>
          <list-item>
            <p><bold>Prognosis:</bold> Rapid progression, wheelchair dependence by adolescence, cardiopulmonary complications.</p>
          </list-item>
        </list>
        <p>
<bold>Becker muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Genetics:</bold> X-linked recessive disorder caused by mutations in the DMD gene.</p>
          </list-item>
          <list-item>
            <p><bold>Onset:</bold> Later than DMD, often in adolescence or adulthood.</p>
          </list-item>
          <list-item>
            <p><bold>Clinical features:</bold> Similar to DMD but with milder symptoms and slower progression.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic tests:</bold> Elevated CK levels, genetic testing for DMD gene mutations.</p>
          </list-item>
          <list-item>
            <p><bold>Prognosis:</bold> Variable, some individuals may remain ambulatory into adulthood.</p>
          </list-item>
        </list>
        <p>
<bold>Myotonic dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Genetics:</bold> Autosomal dominant disorder, involving DMPK gene (DM1) or CNBP gene (DM2).</p>
          </list-item>
          <list-item>
            <p><bold>Clinical features:</bold> Myotonia, muscle wasting, cataracts, cardiac conduction abnormalities.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic tests:</bold> Genetic testing for CTG repeats (DM1) or CCTG repeats (DM2).</p>
          </list-item>
          <list-item>
            <p><bold>Prognosis:</bold> Variable, with a range of severity; may involve multiple systems.</p>
          </list-item>
        </list>
        <p>
<bold>Facioscapulohumeral muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Genetics:</bold> Autosomal dominant disorder, involving DUX4 gene.</p>
          </list-item>
          <list-item>
            <p><bold>Clinical features:</bold> Progressive weakness in face, shoulders, and upper arms.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic tests:</bold> Genetic testing for DUX4 gene mutations.</p>
          </list-item>
          <list-item>
            <p><bold>Prognosis:</bold> Variable, may involve asymmetric muscle weakness.</p>
          </list-item>
        </list>
        <p>
<bold>Limb-Girdle muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Genetics:</bold> Heterogeneous group, both autosomal dominant and recessive forms.</p>
          </list-item>
          <list-item>
            <p><bold>Clinical features:</bold> Proximal muscle weakness in the pelvic and shoulder girdles.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic tests:</bold> Genetic testing for various associated genes associated.</p>
          </list-item>
          <list-item>
            <p><bold>Prognosis:</bold> Variable, depending on the specific subtype.</p>
          </list-item>
        </list>
        <p>
<bold>Emery-Dreifuss muscular dystrophy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Genetics:</bold> X-linked or autosomal dominant, involving EMD and LMNA genes.</p>
          </list-item>
          <list-item>
            <p><bold>Clinical features:</bold> Early contractures, muscle wasting, cardiac conduction abnormalities.</p>
          </list-item>
          <list-item>
            <p><bold>Diagnostic tests:</bold> Genetic testing for EMD and LMNA gene mutations.</p>
          </list-item>
          <list-item>
            <p><bold>Prognosis:</bold> Cardiac complications can be life-threatening.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25401.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Adolescents with muscular dystrophy&#x000a0;require a comprehensive&#x000a0;interprofessional plan of care that addresses various aspects of their health. This includes carefully considering potential&#x000a0;cardiac and&#x000a0;respiratory issues, monitoring&#x000a0;weight changes, addressing concerns related to constipation, addressing rehabilitative and developmental difficulties, attending to psychosocial needs, and managing neurologic and orthopedic problems.<xref ref-type="bibr" rid="article-25401.r212">[212]</xref>&#x000a0;</p>
        <p>Implementing a standardized approach for collecting and sharing data is crucial for optimizing overall performance in various healthcare programs, sites, and organizations.<xref ref-type="bibr" rid="article-25401.r45">[45]</xref> This approach contributes to improved quality of care and reduces disparities in healthcare delivery through the standardization of care practices. Clinicians and healthcare institutions are actively involved in promoting early diagnosis of muscular dystrophy, and a strategic indicator for evaluation could be the percentage of patients undergoing genetic testing or being offered such testing. Clearly defining care goals from the outset provides a framework for other team members to establish their success indicators more precisely.<xref ref-type="bibr" rid="article-25401.r45">[45]</xref>&#x000a0;</p>
        <p>&#x000a0;All healthcare team members must remain well-informed about a patient's condition, fostering effective communication among team members to utilize each profession's expertise. This patient-centered communication approach prioritizes the individual over the disease and can include sharing information about support groups or informative websites. Encouraging patients to participate actively in their care is essential, emphasizing their role in the treatment process. It is crucial to empower patients and their families, moving away from a passive mindset and recognizing their active involvement in their healthcare journey.<xref ref-type="bibr" rid="article-25401.r212">[212]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25401.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25401&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25401">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/muscular-dystrophy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25401">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25401/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25401">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25401.s18">
        <title>References</title>
        <ref id="article-25401.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Whitehead</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Froehner</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.</article-title>
            <source>Physiol Rev</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>253</fpage>
            <page-range>253-305</page-range>
            <pub-id pub-id-type="pmid">26676145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powers</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Zijdewind</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Disease-Induced Skeletal Muscle Atrophy and Fatigue.</article-title>
            <source>Med Sci Sports Exerc</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>11</issue>
            <fpage>2307</fpage>
            <page-range>2307-2319</page-range>
            <pub-id pub-id-type="pmid">27128663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lovering</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The muscular dystrophies: from genes to therapies.</article-title>
            <source>Phys Ther</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>85</volume>
            <issue>12</issue>
            <fpage>1372</fpage>
            <page-range>1372-88</page-range>
            <pub-id pub-id-type="pmid">16305275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brinkmeyer-Langford</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kornegay</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model.</article-title>
            <source>Curr Genomics</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>330</fpage>
            <page-range>330-42</page-range>
            <pub-id pub-id-type="pmid">24403852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendell</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lloyd-Puryear</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy.</article-title>
            <source>Muscle Nerve</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-6</page-range>
            <pub-id pub-id-type="pmid">23716304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Juan-Mateu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gonzalez-Quereda</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Baena</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Verdura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nascimento</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ortez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baiget</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gallano</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>e0135189</fpage>
            <pub-id pub-id-type="pmid">26284620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le Rumeur</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies.</article-title>
            <source>Bosn J Basic Med Sci</source>
            <year>2015</year>
            <month>Jul</month>
            <day>20</day>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>14</fpage>
            <page-range>14-20</page-range>
            <pub-id pub-id-type="pmid">26295289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>QQ</given-names>
              </name>
              <name>
                <surname>McNally</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>The Dystrophin Complex: Structure, Function, and Implications for Therapy.</article-title>
            <source>Compr Physiol</source>
            <year>2015</year>
            <month>Jul</month>
            <day>01</day>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>1223</fpage>
            <page-range>1223-39</page-range>
            <pub-id pub-id-type="pmid">26140716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsuo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Awano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kawaguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Nishio</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.</article-title>
            <source>Genes (Basel)</source>
            <year>2017</year>
            <month>Oct</month>
            <day>02</day>
            <volume>8</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">28974057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buzin</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scaringe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>den Dunnen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mendell</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Sommer</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide.</article-title>
            <source>Hum Mutat</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-88</page-range>
            <pub-id pub-id-type="pmid">15643612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desguerre</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Christov</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zeller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Becane</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Bastuji-Garin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leturcq</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chiron</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chelly</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gherardi</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.</article-title>
            <source>PLoS One</source>
            <year>2009</year>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>e4347</fpage>
            <pub-id pub-id-type="pmid">19194511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von der Hagen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schallner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaindl</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Koehler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mitzscherling</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Abicht</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grieben</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Korinthenberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kress</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>von Moers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Schara</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Vorgerd</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Reible</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>H&#x000fc;bner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lochm&#x000fc;ller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huebner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Facing the genetic heterogeneity in neuromuscular disorders: linkage analysis as an economic diagnostic approach towards the molecular diagnosis.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-13</page-range>
            <pub-id pub-id-type="pmid">16378727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grimm</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liechti-Gallati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bettecken</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis.</article-title>
            <source>J Med Genet</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>183</fpage>
            <page-range>183-6</page-range>
            <pub-id pub-id-type="pmid">8014964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Krawczak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Polychronakos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tyler-Smith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kehrer-Sawatzki</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.</article-title>
            <source>Hum Genet</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>132</volume>
            <issue>10</issue>
            <fpage>1077</fpage>
            <page-range>1077-130</page-range>
            <pub-id pub-id-type="pmid">23820649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Windpassinger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Straub</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hochmeister</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Noor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lohberger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Farra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Petek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schwarzbraun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ofner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>L&#x000f6;scher</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lochm&#x000fc;ller</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Quasthoff</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.</article-title>
            <source>Am J Hum Genet</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-99</page-range>
            <pub-id pub-id-type="pmid">18179888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raffaele Di Barletta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Galluzzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tonali</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morandi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Romorini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Voit</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Orstavik</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Merlini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Trevisan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Biancalana</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Housmanowa-Petrusewicz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bione</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ricotti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bonne</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Toniolo</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.</article-title>
            <source>Am J Hum Genet</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>1407</fpage>
            <page-range>1407-12</page-range>
            <pub-id pub-id-type="pmid">10739764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmood</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>XM</given-names>
              </name>
            </person-group>
            <article-title>Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review).</article-title>
            <source>Mol Med Rep</source>
            <year>2014</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>1515</fpage>
            <page-range>1515-32</page-range>
            <pub-id pub-id-type="pmid">24626787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmood</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Limb-girdle muscular dystrophy subtypes: First-reported cohort from northeastern China.</article-title>
            <source>Neural Regen Res</source>
            <year>2013</year>
            <month>Jul</month>
            <day>15</day>
            <volume>8</volume>
            <issue>20</issue>
            <fpage>1907</fpage>
            <page-range>1907-18</page-range>
            <pub-id pub-id-type="pmid">25206500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rocha</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>267</fpage>
            <page-range>267-76</page-range>
            <pub-id pub-id-type="pmid">20467841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salmikangas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>van der Ven</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Lalowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taivainen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Suila</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schr&#x000f6;der</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lappalainen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>F&#x000fc;rst</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Carp&#x000e9;n</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly.</article-title>
            <source>Hum Mol Genet</source>
            <year>2003</year>
            <month>Jan</month>
            <day>15</day>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-203</page-range>
            <pub-id pub-id-type="pmid">12499399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ki</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Identification of lamin A/C ( LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.</article-title>
            <source>J Hum Genet</source>
            <year>2002</year>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>225</fpage>
            <page-range>225-8</page-range>
            <pub-id pub-id-type="pmid">12032588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sotgia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scartezzini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Broda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bado</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Masetti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mazzocco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Egeo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Volonte</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Galbiati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cordone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bricarelli</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Lisanti</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Zara</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.</article-title>
            <source>Nat Genet</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>365</fpage>
            <page-range>365-8</page-range>
            <pub-id pub-id-type="pmid">9537420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peddareddygari</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Surgan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Grewal</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Limb-girdle muscular dystrophy type 2A resulting from homozygous G2338C transversion mutation in the calpain-3 gene.</article-title>
            <source>J Clin Neuromuscul Dis</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>62</fpage>
            <page-range>62-5</page-range>
            <pub-id pub-id-type="pmid">21386772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cacciottolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Numitone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aurino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caserta</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>Fanin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Politano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Minetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Piluso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nigro</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>9</issue>
            <fpage>974</fpage>
            <page-range>974-80</page-range>
            <pub-id pub-id-type="pmid">21522182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okizuka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takeshima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Awano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumagai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yagi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsuo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Low incidence of limb-girdle muscular dystrophy type 2C revealed by a mutation study in Japanese patients clinically diagnosed with DMD.</article-title>
            <source>BMC Med Genet</source>
            <year>2010</year>
            <month>Mar</month>
            <day>30</day>
            <volume>11</volume>
            <fpage>49</fpage>
            <pub-id pub-id-type="pmid">20350330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diniz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tosun Yildirim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gokben</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Serdaroglu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hazan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yararbas</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tukun</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Concomitant alpha- and gamma-sarcoglycan deficiencies in a Turkish boy with a novel deletion in the alpha-sarcoglycan gene.</article-title>
            <source>Case Rep Genet</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>248561</fpage>
            <pub-id pub-id-type="pmid">25050186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghafouri-Fard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashemi-Gorji</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fardaei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miryounesi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Limb Girdle Muscular Dystrophy Type 2E Due to a Novel Large Deletion in SGCB Gene.</article-title>
            <source>Iran J Child Neurol</source>
            <year>2017</year>
            <season>Summer</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>57</fpage>
            <page-range>57-60</page-range>
            <pub-id pub-id-type="pmid">28883879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nigro</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>de S&#x000e1; Moreira</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Piluso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vainzof</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Belsito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Politano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Puca</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Passos-Bueno</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Zatz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene.</article-title>
            <source>Nat Genet</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-8</page-range>
            <pub-id pub-id-type="pmid">8841194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moreira</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Wiltshire</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Faulkner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nilforoushan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vainzof</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>OT</given-names>
              </name>
              <name>
                <surname>Valle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zatz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Passos-Bueno</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Jenne</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin.</article-title>
            <source>Nat Genet</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>163</fpage>
            <page-range>163-6</page-range>
            <pub-id pub-id-type="pmid">10655062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frosk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Weiler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nylen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sudha</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Wrogemann</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.</article-title>
            <source>Am J Hum Genet</source>
            <year>2002</year>
            <month>Mar</month>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>663</fpage>
            <page-range>663-72</page-range>
            <pub-id pub-id-type="pmid">11822024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>LU</given-names>
              </name>
              <name>
                <surname>Velloso</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Foga&#x000e7;a</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>de Paula</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vieira</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Zatz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vainzof</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Muscle protein alterations in LGMD2I patients with different mutations in the Fukutin-related protein gene.</article-title>
            <source>J Histochem Cytochem</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>56</volume>
            <issue>11</issue>
            <fpage>995</fpage>
            <page-range>995-1001</page-range>
            <pub-id pub-id-type="pmid">18645206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Maarel</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Deidda</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lemmers</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>van Overveld</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>van der Wielen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hewitt</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sandkuijl</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>van Ommen</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Padberg</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Frants</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.</article-title>
            <source>Am J Hum Genet</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-35</page-range>
            <pub-id pub-id-type="pmid">10631134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zernov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Skoblov</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Genotype-phenotype correlations in FSHD.</article-title>
            <source>BMC Med Genomics</source>
            <year>2019</year>
            <month>Mar</month>
            <day>13</day>
            <volume>12</volume>
            <issue>Suppl 2</issue>
            <fpage>43</fpage>
            <pub-id pub-id-type="pmid">30871534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurzau</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lucet</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Ly</surname>
                <given-names>TTN</given-names>
              </name>
              <name>
                <surname>Reversade</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blewitt</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.</article-title>
            <source>J Biol Chem</source>
            <year>2018</year>
            <month>Jun</month>
            <day>22</day>
            <volume>293</volume>
            <issue>25</issue>
            <fpage>9841</fpage>
            <page-range>9841-9853</page-range>
            <pub-id pub-id-type="pmid">29748383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Botta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vallo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bonifazi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Amati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Biancolella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gambardella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mancinelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Novelli</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.</article-title>
            <source>Gene Expr</source>
            <year>2007</year>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>339</fpage>
            <page-range>339-51</page-range>
            <pub-id pub-id-type="pmid">17708420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Llamus&#x000ed;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Artero</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.</article-title>
            <source>Curr Genomics</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>509</fpage>
            <page-range>509-16</page-range>
            <pub-id pub-id-type="pmid">19516957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yum</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Kalsotra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes.</article-title>
            <source>Curr Opin Genet Dev</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>44</volume>
            <fpage>30</fpage>
            <page-range>30-37</page-range>
            <pub-id pub-id-type="pmid">28213156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paulson</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Repeat expansion diseases.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2018</year>
            <volume>147</volume>
            <fpage>105</fpage>
            <page-range>105-123</page-range>
            <pub-id pub-id-type="pmid">29325606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahrizaila</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kinnear</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Wills</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Respiratory involvement in inherited primary muscle conditions.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>77</volume>
            <issue>10</issue>
            <fpage>1108</fpage>
            <page-range>1108-15</page-range>
            <pub-id pub-id-type="pmid">16980655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ricker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grimm</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kress</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Reimers</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Schulte-Mattler</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mueller-Myhsok</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Toyka</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Linkage of proximal myotonic myopathy to chromosome 3q.</article-title>
            <source>Neurology</source>
            <year>1999</year>
            <month>Jan</month>
            <day>01</day>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>170</fpage>
            <page-range>170-1</page-range>
            <pub-id pub-id-type="pmid">9921867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brais</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rouleau</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Bouchard</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fardeau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tom&#x000e9;</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Oculopharyngeal muscular dystrophy.</article-title>
            <source>Semin Neurol</source>
            <year>1999</year>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-66</page-range>
            <pub-id pub-id-type="pmid">10711989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahimov</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kunkel</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy.</article-title>
            <source>J Cell Biol</source>
            <year>2013</year>
            <month>May</month>
            <day>13</day>
            <volume>201</volume>
            <issue>4</issue>
            <fpage>499</fpage>
            <page-range>499-510</page-range>
            <pub-id pub-id-type="pmid">23671309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellayou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hamzi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rafai</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Karkouri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Slassi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Azeddoug</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nadifi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Duchenne and Becker muscular dystrophy: contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco.</article-title>
            <source>J Biomed Biotechnol</source>
            <year>2009</year>
            <volume>2009</volume>
            <fpage>325210</fpage>
            <pub-id pub-id-type="pmid">19461958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aartsma-Rus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Deutekom</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fokkema</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Van Ommen</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Den Dunnen</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.</article-title>
            <source>Muscle Nerve</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-44</page-range>
            <pub-id pub-id-type="pmid">16770791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mah</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Current and emerging treatment strategies for Duchenne muscular dystrophy.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2016</year>
            <volume>12</volume>
            <fpage>1795</fpage>
            <page-range>1795-807</page-range>
            <pub-id pub-id-type="pmid">27524897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobs</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bart</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: further evidence that the DMD locus is at Xp21.</article-title>
            <source>Am J Hum Genet</source>
            <year>1981</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>513</fpage>
            <page-range>513-8</page-range>
            <pub-id pub-id-type="pmid">7258185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruz Guzm&#x000e1;n</surname>
                <given-names>Odel R</given-names>
              </name>
              <name>
                <surname>Ch&#x000e1;vez Garc&#x000ed;a</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Cruz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Muscular dystrophies at different ages: metabolic and endocrine alterations.</article-title>
            <source>Int J Endocrinol</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>485376</fpage>
            <pub-id pub-id-type="pmid">22701119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theadom</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roxburgh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Balalla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bhattacharjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Krishnamurthi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Feigin</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of muscular dystrophies: a systematic literature review.</article-title>
            <source>Neuroepidemiology</source>
            <year>2014</year>
            <volume>43</volume>
            <issue>3-4</issue>
            <fpage>259</fpage>
            <page-range>259-68</page-range>
            <pub-id pub-id-type="pmid">25532075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mah</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Korngut</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fiest</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Dykeman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Pringsheim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jette</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.</article-title>
            <source>Can J Neurol Sci</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>163</fpage>
            <page-range>163-77</page-range>
            <pub-id pub-id-type="pmid">26786644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suominen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bachinski</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Auvinen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hackman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baggerly</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peltonen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Krahe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Udd</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>7</issue>
            <fpage>776</fpage>
            <page-range>776-82</page-range>
            <pub-id pub-id-type="pmid">21364698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashizawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gagnon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Gutmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Angeard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bassez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Berggren</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Bhakta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bozzali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>JLB</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cup</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>De Mattia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Duboc</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Duong</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eichinger</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ekstrom</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>van Engelen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Esparis</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eymard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ferschl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gadalla</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gallais</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goodglick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Heatwole</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hilbert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kierkegaard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koopman</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Maas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mankodi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Monckton</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nazarian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Phetteplace</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Puymirat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Richer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sansone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sterling</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Statland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Subramony</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trujillo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tomaselli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Venance</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winblad</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Consensus-based care recommendations for adults with myotonic dystrophy type 1.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>507</fpage>
            <page-range>507-520</page-range>
            <pub-id pub-id-type="pmid">30588381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stark</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Determinants of the incidence of Duchenne muscular dystrophy.</article-title>
            <source>Ann Transl Med</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>3</volume>
            <issue>19</issue>
            <fpage>287</fpage>
            <pub-id pub-id-type="pmid">26697447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mah</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Korngut</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dykeman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pringsheim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jette</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>482</fpage>
            <page-range>482-91</page-range>
            <pub-id pub-id-type="pmid">24780148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bushby</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Thambyayah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gardner-Medwin</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and incidence of Becker muscular dystrophy.</article-title>
            <source>Lancet</source>
            <year>1991</year>
            <month>Apr</month>
            <day>27</day>
            <volume>337</volume>
            <issue>8748</issue>
            <fpage>1022</fpage>
            <page-range>1022-4</page-range>
            <pub-id pub-id-type="pmid">1673177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mostacciuolo</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Miorin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Perini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trevisan</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy.</article-title>
            <source>Hum Genet</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>97</volume>
            <issue>3</issue>
            <fpage>277</fpage>
            <page-range>277-9</page-range>
            <pub-id pub-id-type="pmid">8786062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graziano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bianco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moroni</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Messina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pegoraro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Astrea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Magri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Berardinelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moggio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morandi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petillo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tasca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Monforte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Minetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mongini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gorni</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Battini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Villanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Politano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gualandi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferlini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muntoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Santorelli</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pane</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mercuri</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of congenital muscular dystrophy in Italy: a population study.</article-title>
            <source>Neurology</source>
            <year>2015</year>
            <month>Mar</month>
            <day>03</day>
            <volume>84</volume>
            <issue>9</issue>
            <fpage>904</fpage>
            <page-range>904-11</page-range>
            <pub-id pub-id-type="pmid">25653289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peterlin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zidar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meznaric-Petrusa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zupancic</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Genetic epidemiology of Duchenne and Becker muscular dystrophy in Slovenia.</article-title>
            <source>Clin Genet</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-7</page-range>
            <pub-id pub-id-type="pmid">9111995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norwood</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Harling</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chinnery</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bushby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Straub</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.</article-title>
            <source>Brain</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>Pt 11</issue>
            <fpage>3175</fpage>
            <page-range>3175-86</page-range>
            <pub-id pub-id-type="pmid">19767415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>C&#x000f4;t&#x000e9;</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Rotundo</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Carbonetto</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane.</article-title>
            <source>J Cell Biol</source>
            <year>2001</year>
            <month>Feb</month>
            <day>05</day>
            <volume>152</volume>
            <issue>3</issue>
            <fpage>435</fpage>
            <page-range>435-50</page-range>
            <pub-id pub-id-type="pmid">11157973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montanaro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lindenbaum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carbonetto</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability.</article-title>
            <source>J Cell Biol</source>
            <year>1999</year>
            <month>Jun</month>
            <day>14</day>
            <volume>145</volume>
            <issue>6</issue>
            <fpage>1325</fpage>
            <page-range>1325-40</page-range>
            <pub-id pub-id-type="pmid">10366602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shivers</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Atkinson</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>The dystrophic murine skeletal muscle cell plasma membrane is structurally intact but "leaky" to creatine phosphokinase. A freeze-fracture analysis.</article-title>
            <source>Am J Pathol</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>482</fpage>
            <page-range>482-96</page-range>
            <pub-id pub-id-type="pmid">6476081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Cappel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vester</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Samaha</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Gruenstein</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.</article-title>
            <source>Muscle Nerve</source>
            <year>1982</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">7057800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuller</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Fries</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Golbus</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis of Duchenne muscular dystrophy by fetal muscle biopsy.</article-title>
            <source>Hum Genet</source>
            <year>1992</year>
            <season>Sep-Oct</season>
            <volume>90</volume>
            <issue>1-2</issue>
            <fpage>34</fpage>
            <page-range>34-40</page-range>
            <pub-id pub-id-type="pmid">1427785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adams</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Brancaccio</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The evolution of the dystroglycan complex, a major mediator of muscle integrity.</article-title>
            <source>Biol Open</source>
            <year>2015</year>
            <month>Aug</month>
            <day>28</day>
            <volume>4</volume>
            <issue>9</issue>
            <fpage>1163</fpage>
            <page-range>1163-79</page-range>
            <pub-id pub-id-type="pmid">26319583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barresi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Dystroglycan: from biosynthesis to pathogenesis of human disease.</article-title>
            <source>J Cell Sci</source>
            <year>2006</year>
            <month>Jan</month>
            <day>15</day>
            <volume>119</volume>
            <issue>Pt 2</issue>
            <fpage>199</fpage>
            <page-range>199-207</page-range>
            <pub-id pub-id-type="pmid">16410545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kharraz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pessina</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Serrano</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-C&#x000e1;noves</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Understanding the process of fibrosis in Duchenne muscular dystrophy.</article-title>
            <source>Biomed Res Int</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>965631</fpage>
            <pub-id pub-id-type="pmid">24877152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klingler</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Jurkat-Rott</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lehmann-Horn</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schleip</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The role of fibrosis in Duchenne muscular dystrophy.</article-title>
            <source>Acta Myol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>184</fpage>
            <page-range>184-95</page-range>
            <pub-id pub-id-type="pmid">23620650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Taguchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Malignant hyperthermia.</article-title>
            <source>Best Pract Res Clin Anaesthesiol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>519</fpage>
            <page-range>519-33</page-range>
            <pub-id pub-id-type="pmid">14661655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pollock</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stowell</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Malignant hyperthermia.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2007</year>
            <month>Apr</month>
            <day>24</day>
            <volume>2</volume>
            <fpage>21</fpage>
            <pub-id pub-id-type="pmid">17456235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cyrulnik</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Fee</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>De Vivo</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hinton</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>Delayed developmental language milestones in children with Duchenne's muscular dystrophy.</article-title>
            <source>J Pediatr</source>
            <year>2007</year>
            <month>May</month>
            <volume>150</volume>
            <issue>5</issue>
            <fpage>474</fpage>
            <page-range>474-8</page-range>
            <pub-id pub-id-type="pmid">17452219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andrews</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Wahl</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Duchenne and Becker muscular dystrophy in adolescents: current perspectives.</article-title>
            <source>Adolesc Health Med Ther</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>53</fpage>
            <page-range>53-63</page-range>
            <pub-id pub-id-type="pmid">29588625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Mickelson</surname>
                <given-names>ECR</given-names>
              </name>
              <name>
                <surname>Zwicker</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of developmental coordination disorder.</article-title>
            <source>CMAJ</source>
            <year>2015</year>
            <month>Jun</month>
            <day>16</day>
            <volume>187</volume>
            <issue>9</issue>
            <fpage>659</fpage>
            <page-range>659-665</page-range>
            <pub-id pub-id-type="pmid">26009588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sutherland</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Olshen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wyatt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mubarak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The pathomechanics of gait in Duchenne muscular dystrophy.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>1981</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-22</page-range>
            <pub-id pub-id-type="pmid">7202868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bendixen</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Houtrow</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Parental Reflections on the Diagnostic Process for Duchenne Muscular Dystrophy: A Qualitative Study.</article-title>
            <source>J Pediatr Health Care</source>
            <year>2017</year>
            <season>May-Jun</season>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>285</fpage>
            <page-range>285-292</page-range>
            <pub-id pub-id-type="pmid">27743907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barohn</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Dimachkie</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>A pattern recognition approach to patients with a suspected myopathy.</article-title>
            <source>Neurol Clin</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>569</fpage>
            <page-range>569-93, vii</page-range>
            <pub-id pub-id-type="pmid">25037080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khaitan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Duchenne muscular dystrophy: Case report and review.</article-title>
            <source>J Family Med Prim Care</source>
            <year>2017</year>
            <season>Jul-Sep</season>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>654</fpage>
            <page-range>654-656</page-range>
            <pub-id pub-id-type="pmid">29417026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases.</article-title>
            <source>Phys Med Rehabil Clin N Am</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>495</fpage>
            <page-range>495-563</page-range>
            <pub-id pub-id-type="pmid">22938875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoshioka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yorifuji</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mituyoshi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy.</article-title>
            <source>Clin Genet</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-7</page-range>
            <pub-id pub-id-type="pmid">9611069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tay</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Transaminitis in Duchenne's muscular dystrophy.</article-title>
            <source>Ann Acad Med Singap</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>719</fpage>
            <page-range>719-22</page-range>
            <pub-id pub-id-type="pmid">11269976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marks</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>GHW</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>The genetic basis of disease.</article-title>
            <source>Essays Biochem</source>
            <year>2018</year>
            <month>Dec</month>
            <day>03</day>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>643</fpage>
            <page-range>643-723</page-range>
            <pub-id pub-id-type="pmid">30509934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nozoe</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Akamine</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Mazzotti</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Polesel</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Grossklauss</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Tufik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Moreira</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic contrasts of Duchenne Muscular Dystrophy in women: Two case reports.</article-title>
            <source>Sleep Sci</source>
            <year>2016</year>
            <season>Jul-Sep</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>129</fpage>
            <page-range>129-133</page-range>
            <pub-id pub-id-type="pmid">28123647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo Mauro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aliverti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Physiology of respiratory disturbances in muscular dystrophies.</article-title>
            <source>Breathe (Sheff)</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>318</fpage>
            <page-range>318-327</page-range>
            <pub-id pub-id-type="pmid">28210319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takeshima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Awano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okizuka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yagi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsuo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>High incidence of electrocardiogram abnormalities in young patients with duchenne muscular dystrophy.</article-title>
            <source>Pediatr Neurol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>399</fpage>
            <page-range>399-403</page-range>
            <pub-id pub-id-type="pmid">19027585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r84">
          <label>84</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bird</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <chapter-title>Myotonic Dystrophy Type 1</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1999</year>
            <month>9</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">20301344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pelargonio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dello Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanna</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>De Martino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bellocci</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy and the heart.</article-title>
            <source>Heart</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>88</volume>
            <issue>6</issue>
            <fpage>665</fpage>
            <page-range>665-70</page-range>
            <pub-id pub-id-type="pmid">12433913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajdev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Arrhythmias in the muscular dystrophies.</article-title>
            <source>Card Electrophysiol Clin</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>303</fpage>
            <page-range>303-8</page-range>
            <pub-id pub-id-type="pmid">26002394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollinsky</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kutter</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Geiger</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Long-term ventilation of patients with Duchenne muscular dystrophy: experiences at the Neuromuscular Centre Ulm.</article-title>
            <source>Acta Myol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-8</page-range>
            <pub-id pub-id-type="pmid">23620648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathew</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Navaratnam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rana</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Harkness</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>O'Gallagher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oxborough</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ring</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sandoval</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Steeds</surname>
                <given-names>RP</given-names>
              </name>
              <collab>British Society of Echocardiography Education Committee</collab>
            </person-group>
            <article-title>Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography.</article-title>
            <source>Echo Res Pract</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>G1</fpage>
            <page-range>G1-G13</page-range>
            <pub-id pub-id-type="pmid">28592613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mestroni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Brun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spezzacatene</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sinagra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>GENETIC CAUSES OF DILATED CARDIOMYOPATHY.</article-title>
            <source>Prog Pediatr Cardiol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>1-2</issue>
            <fpage>13</fpage>
            <page-range>13-18</page-range>
            <pub-id pub-id-type="pmid">25584016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verhaert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rafael-Fortney</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Raman</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-76</page-range>
            <pub-id pub-id-type="pmid">21245364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mavrogeni</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Markousis-Mavrogenis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papavasiliou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kolovou</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.</article-title>
            <source>Methods Mol Biol</source>
            <year>2018</year>
            <volume>1687</volume>
            <fpage>31</fpage>
            <page-range>31-42</page-range>
            <pub-id pub-id-type="pmid">29067654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oldfors</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eriksson</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Kyllerman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinsson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wahlstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Dilated cardiomyopathy and the dystrophin gene: an illustrated review.</article-title>
            <source>Br Heart J</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>344</fpage>
            <page-range>344-8</page-range>
            <pub-id pub-id-type="pmid">7833192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Connuck</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Sleeper</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Colan</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Towbin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Orav</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Cuniberti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salbert</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Lipshultz</surname>
                <given-names>SE</given-names>
              </name>
              <collab>Pediatric Cardiomyopathy Registry Study Group</collab>
            </person-group>
            <article-title>Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.</article-title>
            <source>Am Heart J</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>155</volume>
            <issue>6</issue>
            <fpage>998</fpage>
            <page-range>998-1005</page-range>
            <pub-id pub-id-type="pmid">18513510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D&#x000ed;az-Manera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Llauger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gallardo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Illa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Muscle MRI in muscular dystrophies.</article-title>
            <source>Acta Myol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>2-3</issue>
            <fpage>95</fpage>
            <page-range>95-108</page-range>
            <pub-id pub-id-type="pmid">27199536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schilling</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Forst</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Forst</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fujak</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Orthopaedic Disorders in Myotonic Dystrophy Type 1: descriptive clinical study of 21 patients.</article-title>
            <source>BMC Musculoskelet Disord</source>
            <year>2013</year>
            <month>Dec</month>
            <day>01</day>
            <volume>14</volume>
            <fpage>338</fpage>
            <pub-id pub-id-type="pmid">24289806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M King</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kissel</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary approach to the management of myopathies.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>6 Muscle Disease</issue>
            <fpage>1650</fpage>
            <page-range>1650-73</page-range>
            <pub-id pub-id-type="pmid">24305452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelliaume</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lalioui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delgove</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lef&#x000e8;vre</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Tailor-made management of thoracic scoliosis with cervical hyperextension in muscular dystrophy.</article-title>
            <source>Eur Spine J</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>264</fpage>
            <page-range>264-269</page-range>
            <pub-id pub-id-type="pmid">28593385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Two cases of myotonic dystrophy manifesting various ophthalmic findings with genetic evaluation.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>535</fpage>
            <page-range>535-7</page-range>
            <pub-id pub-id-type="pmid">27609169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skalsky</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Prevention and management of limb contractures in neuromuscular diseases.</article-title>
            <source>Phys Med Rehabil Clin N Am</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>675</fpage>
            <page-range>675-87</page-range>
            <pub-id pub-id-type="pmid">22938881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Chun</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>HI</given-names>
              </name>
            </person-group>
            <article-title>Lower extremity joint contracture according to ambulatory status in children with Duchenne muscular dystrophy.</article-title>
            <source>BMC Musculoskelet Disord</source>
            <year>2018</year>
            <month>Aug</month>
            <day>16</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>287</fpage>
            <pub-id pub-id-type="pmid">30111310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ricci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zatz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tupler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.</article-title>
            <source>Curr Mol Med</source>
            <year>2014</year>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>1052</fpage>
            <page-range>1052-1068</page-range>
            <pub-id pub-id-type="pmid">25323867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sackley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Disler</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Turner-Stokes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wade</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Brittle</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hoppitt</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Rehabilitation interventions for foot drop in neuromuscular disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2009</year>
            <month>Jul</month>
            <day>08</day>
            <issue>3</issue>
            <fpage>CD003908</fpage>
            <pub-id pub-id-type="pmid">19588347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gissy</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ciafaloni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Essen</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Peay</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Finkel</surname>
                <given-names>RS</given-names>
              </name>
              <collab>MD STARnet</collab>
            </person-group>
            <article-title>Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>905</fpage>
            <page-range>905-910</page-range>
            <pub-id pub-id-type="pmid">28739181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Salajegheh</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Myotonic disorders: A review article.</article-title>
            <source>Iran J Neurol</source>
            <year>2016</year>
            <month>Jan</month>
            <day>05</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-53</page-range>
            <pub-id pub-id-type="pmid">27141276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barzegar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niknam</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Habibi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shiva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tahmasebi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Bone Mineral Density and Bone Metabolism in Patients with Duchenne Muscular Dystrophy.</article-title>
            <source>Iran J Child Neurol</source>
            <year>2018</year>
            <season>Winter</season>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-83</page-range>
            <pub-id pub-id-type="pmid">29379565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nereo</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Fee</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hinton</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>Parental stress in mothers of boys with duchenne muscular dystrophy.</article-title>
            <source>J Pediatr Psychol</source>
            <year>2003</year>
            <season>Oct-Nov</season>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>473</fpage>
            <page-range>473-84</page-range>
            <pub-id pub-id-type="pmid">12968039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Partridge</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Could exon skipping help dystrophic boys to run, hop, and jump?</article-title>
            <source>Mol Ther</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>11</issue>
            <fpage>1884</fpage>
            <page-range>1884-6</page-range>
            <pub-id pub-id-type="pmid">25365985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Mubarak</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Pathomechanics of Gowers' sign: a video analysis of a spectrum of Gowers' maneuvers.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>470</volume>
            <issue>7</issue>
            <fpage>1987</fpage>
            <page-range>1987-91</page-range>
            <pub-id pub-id-type="pmid">22203329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birnkrant</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bushby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bann</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Apkon</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brumbaugh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Case</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Clemens</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Hadjiyannakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Street</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tomezsko</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>DR</given-names>
              </name>
              <collab>DMD Care Considerations Working Group</collab>
            </person-group>
            <article-title>Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.</article-title>
            <source>Lancet Neurol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-267</page-range>
            <pub-id pub-id-type="pmid">29395989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kornegay</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Childers</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Bogan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bogan</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Nghiem</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Schatzberg</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Dow</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Grange</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Styner</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>The paradox of muscle hypertrophy in muscular dystrophy.</article-title>
            <source>Phys Med Rehabil Clin N Am</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>149</fpage>
            <page-range>149-72, xii</page-range>
            <pub-id pub-id-type="pmid">22239881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koenig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beggs</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Moyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scherpf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heindrich</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bettecken</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Lindl&#x000f6;f</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaariainen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de la Chapellet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kiuru</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Savontaus</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gilgenkrantz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>R&#x000e9;can</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chelly</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Covone</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Archidiacono</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Romeo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liechti-Gailati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Braga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Darras</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Francke</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Denton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Wrogemann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Blonden</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>van Paassen</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>van Ommen</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Kunkel</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.</article-title>
            <source>Am J Hum Genet</source>
            <year>1989</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>498</fpage>
            <page-range>498-506</page-range>
            <pub-id pub-id-type="pmid">2491009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mateos-Aierdi</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Goicoechea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aiastui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Torr&#x000f3;n</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garcia-Puga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matheu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez de Munain</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Muscle wasting in myotonic dystrophies: a model of premature aging.</article-title>
            <source>Front Aging Neurosci</source>
            <year>2015</year>
            <volume>7</volume>
            <fpage>125</fpage>
            <pub-id pub-id-type="pmid">26217220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reimers</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Schlotter</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eicke</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Witt</surname>
                <given-names>TN</given-names>
              </name>
            </person-group>
            <article-title>Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature.</article-title>
            <source>J Neurol Sci</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>143</volume>
            <issue>1-2</issue>
            <fpage>46</fpage>
            <page-range>46-56</page-range>
            <pub-id pub-id-type="pmid">8981297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marden</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging.</article-title>
            <source>Skeletal Radiol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>140</fpage>
            <page-range>140-8</page-range>
            <pub-id pub-id-type="pmid">15538561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mercuri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sabatelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morandi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sewry</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brockington</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ferreiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maraldi</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Toda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Guicheney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Merlini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Muntoni</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Congenital muscular dystrophy associated with calf hypertrophy, microcephaly and severe mental retardation in three Italian families: evidence for a novel CMD syndrome.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>541</fpage>
            <page-range>541-7</page-range>
            <pub-id pub-id-type="pmid">11053679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacomis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Electrodiagnostic approach to the patient with suspected myopathy.</article-title>
            <source>Neurol Clin</source>
            <year>2002</year>
            <month>May</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>587</fpage>
            <page-range>587-603</page-range>
            <pub-id pub-id-type="pmid">12152448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r117">
          <label>117</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pegoraro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <chapter-title>Limb-Girdle Muscular Dystrophy Overview &#x02013; RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2000</year>
            <month>6</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">20301582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forst</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Forst</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Hengstler</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Characteristics in the treatment of scoliosis in muscular diseases].</article-title>
            <source>Z Orthop Ihre Grenzgeb</source>
            <year>1997</year>
            <season>Mar-Apr</season>
            <volume>135</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-105</page-range>
            <pub-id pub-id-type="pmid">9214180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ropars</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lempereur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vuillerot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tiffreau</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Peudenier</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cuisset</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Pereon</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Leboeuf</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Delporte</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Delpierre</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brochard</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>e0161938</fpage>
            <pub-id pub-id-type="pmid">27622734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gijsbertse</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goselink</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lassche</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nillesen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sprengers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Verdonschot</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van Alfen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Korte</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.</article-title>
            <source>Ultrasound Med Biol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>11</issue>
            <fpage>2537</fpage>
            <page-range>2537-2545</page-range>
            <pub-id pub-id-type="pmid">28764967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pinzan</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Advances in imaging of brain abnormalities in neuromuscular disease.</article-title>
            <source>Ther Adv Neurol Disord</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>1756286419845567</fpage>
            <pub-id pub-id-type="pmid">31105770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Angelo</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Lorusso</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Civati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Magri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Del Bo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guglieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Molteni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Turconi</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bresolin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site.</article-title>
            <source>Pediatr Neurol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>292</fpage>
            <page-range>292-9</page-range>
            <pub-id pub-id-type="pmid">22000308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cardamone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farrar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.</article-title>
            <source>World J Clin Pediatr</source>
            <year>2015</year>
            <month>Nov</month>
            <day>08</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>66</fpage>
            <page-range>66-80</page-range>
            <pub-id pub-id-type="pmid">26566479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chamova</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Guergueltcheva</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Raycheva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Todorov</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Genova</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bichev</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bojinova</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mitev</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tournev</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Todorova</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies.</article-title>
            <source>Balkan J Med Genet</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-30</page-range>
            <pub-id pub-id-type="pmid">24265581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumagai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Miura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miyazaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ochi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>[Central nervous system involvements in Duchenne/Becker muscular dystrophy].</article-title>
            <source>No To Hattatsu</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>480</fpage>
            <page-range>480-6</page-range>
            <pub-id pub-id-type="pmid">11725514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gadoth</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Oksenberg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sleep and sleep disorders in rare hereditary diseases: a reminder for the pediatrician, pediatric and adult neurologist, general practitioner, and sleep specialist.</article-title>
            <source>Front Neurol</source>
            <year>2014</year>
            <volume>5</volume>
            <fpage>133</fpage>
            <pub-id pub-id-type="pmid">25101051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Echenne</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rivier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jellali</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Azais</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mornet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pons</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Merosin positive congenital muscular dystrophy with mental deficiency, epilepsy and MRI changes in the cerebral white matter.</article-title>
            <source>Neuromuscul Disord</source>
            <year>1997</year>
            <month>May</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>187</fpage>
            <page-range>187-90</page-range>
            <pub-id pub-id-type="pmid">9185183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r128">
          <label>128</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sparks</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Quijano-Roy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rutkowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Pegoraro</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <chapter-title>Congenital Muscular Dystrophy Overview &#x02013; RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2001</year>
            <month>1</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">20301468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Louprasong</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Diller</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Spider dystrophy as an ocular manifestation of myotonic dystrophy.</article-title>
            <source>Optometry</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>188</fpage>
            <page-range>188-93</page-range>
            <pub-id pub-id-type="pmid">20346890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dreimann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kossow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hitzl</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Koller</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Scoliosis and chest cage deformity measures predicting impairments in pulmonary function: a cross-sectional study of 492 patients with scoliosis to improve the early identification of patients at risk.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>2014</year>
            <month>Nov</month>
            <day>15</day>
            <volume>39</volume>
            <issue>24</issue>
            <fpage>2024</fpage>
            <page-range>2024-33</page-range>
            <pub-id pub-id-type="pmid">25202929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Bonnemann</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Rutkowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sejersen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bellini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Battista</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Florence</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schara</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schuler</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Wahbi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aloysius</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bash</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>B&#x000e9;roud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bushby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Deconinck</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Desguerre</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Estournet-Mathiaud</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ferreiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fujak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goemans</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Iannaccone</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Jouinot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Main</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Melacini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mueller-Felber</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Muntoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Rahbek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quijano-Roy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sewry</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Storhaug</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Simonds</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vajsar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vianello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zeller</surname>
                <given-names>R</given-names>
              </name>
              <collab>International Standard of Care Committee for Congenital Muscular Dystrophy</collab>
            </person-group>
            <article-title>Consensus statement on standard of care for congenital muscular dystrophies.</article-title>
            <source>J Child Neurol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>1559</fpage>
            <page-range>1559-81</page-range>
            <pub-id pub-id-type="pmid">21078917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinane</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Duda</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Lowes</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Moody</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Mendell</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History.</article-title>
            <source>J Neuromuscul Dis</source>
            <year>2018</year>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-58</page-range>
            <pub-id pub-id-type="pmid">29278896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mangera</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Panesar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Makker</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Practical approach to management of respiratory complications in neurological disorders.</article-title>
            <source>Int J Gen Med</source>
            <year>2012</year>
            <volume>5</volume>
            <fpage>255</fpage>
            <page-range>255-63</page-range>
            <pub-id pub-id-type="pmid">22505823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howard</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Long term ventilation in neurogenic respiratory failure.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>74 Suppl 3</volume>
            <issue>Suppl 3</issue>
            <fpage>iii24</fpage>
            <page-range>iii24-30</page-range>
            <pub-id pub-id-type="pmid">12933911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sakinci</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ersoy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sezer</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Assessment of sleep-related breathing disorders in patients with duchenne muscular dystrophy.</article-title>
            <source>J Clin Med Res</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>332</fpage>
            <page-range>332-7</page-range>
            <pub-id pub-id-type="pmid">23024736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacLeod</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robb</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Borzyskowski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bladder dysfunction in Duchenne muscular dystrophy.</article-title>
            <source>Arch Dis Child</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>88</volume>
            <issue>4</issue>
            <fpage>347</fpage>
            <page-range>347-9</page-range>
            <pub-id pub-id-type="pmid">12651768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.</article-title>
            <source>Acta Myol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>154</fpage>
            <page-range>154-65</page-range>
            <pub-id pub-id-type="pmid">24803843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reiter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gramer</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Anticipation in patients with iridescent multicoloured posterior capsular lens opacities ("Christmas tree cataract") : The Role in the diagnosis of myotonic dystrophy].</article-title>
            <source>Ophthalmologe</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>106</volume>
            <issue>12</issue>
            <fpage>1116</fpage>
            <page-range>1116-20</page-range>
            <pub-id pub-id-type="pmid">19326122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Doo</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy type 1 presenting as male infertility.</article-title>
            <source>Korean J Urol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-6</page-range>
            <pub-id pub-id-type="pmid">22379595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peric</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nisic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Milicev</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Basta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Marjanovic</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Peric</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lavrnic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rakocevic Stojanovic</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Hypogonadism and erectile dysfunction in myotonic dystrophy type 1.</article-title>
            <source>Acta Myol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-9</page-range>
            <pub-id pub-id-type="pmid">24399868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo Cascio</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Goetze</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Latshang</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Bluemel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Frauenfelder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>e0163779</fpage>
            <pub-id pub-id-type="pmid">27736891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r142">
          <label>142</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stasi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mumolo</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Ricchiuti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marchi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal manifestations in myotonic muscular dystrophy.</article-title>
            <source>World J Gastroenterol</source>
            <year>2006</year>
            <month>Mar</month>
            <day>28</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>1821</fpage>
            <page-range>1821-8</page-range>
            <pub-id pub-id-type="pmid">16609987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r143">
          <label>143</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller-Lissner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stanghellini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Boeckxstaens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kamm</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Simren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Galmiche</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of chronic constipation--a European perspective.</article-title>
            <source>Neurogastroenterol Motil</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>8</issue>
            <fpage>697</fpage>
            <page-range>697-710</page-range>
            <pub-id pub-id-type="pmid">21605282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r144">
          <label>144</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clav&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shaker</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Dysphagia: current reality and scope of the problem.</article-title>
            <source>Nat Rev Gastroenterol Hepatol</source>
            <year>2015</year>
            <month>May</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>259</fpage>
            <page-range>259-70</page-range>
            <pub-id pub-id-type="pmid">25850008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r145">
          <label>145</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erdenen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Toros</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Uzum</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sacak</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Steinert's syndrome presenting as anal incontinence: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2011</year>
            <month>Aug</month>
            <day>12</day>
            <volume>5</volume>
            <fpage>371</fpage>
            <pub-id pub-id-type="pmid">21838873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r146">
          <label>146</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Cruz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Atilano-Miguel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barbosa-Cort&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bernab&#x000e9;-Garc&#x000ed;a</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Almeida-Becerril</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>C&#x000e1;rdenas-Conejo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Del Roc&#x000ed;o Cruz-Guzm&#x000e1;n</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maldonado-Hern&#x000e1;ndez</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Evidence of muscle loss delay and improvement of hyperinsulinemia and insulin resistance in Duchenne muscular dystrophy supplemented with omega-3 fatty acids: A randomized study.</article-title>
            <source>Clin Nutr</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>2087</fpage>
            <page-range>2087-2097</page-range>
            <pub-id pub-id-type="pmid">30420291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r147">
          <label>147</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hathout</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Seol</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Clinical utility of serum biomarkers in Duchenne muscular dystrophy.</article-title>
            <source>Clin Proteomics</source>
            <year>2016</year>
            <volume>13</volume>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">27051355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r148">
          <label>148</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takasugi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishihara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Toyoda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Oosumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishio</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aoyagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawashiro</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Blood gas changes in Duchenne type muscular dystrophy].</article-title>
            <source>Nihon Kyobu Shikkan Gakkai Zasshi</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-22</page-range>
            <pub-id pub-id-type="pmid">7699962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r149">
          <label>149</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubegni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malandrini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dosi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Astrea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baldacci</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Battisti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertocci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dotti</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Federico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Grosso</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guerrini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lenzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maioli</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Melani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mercuri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sacchini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salvatore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Siciliano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tolomeo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tonin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Volpi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Santorelli</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Cassandrini</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Next-generation sequencing approach to hyperCKemia: A 2-year cohort study.</article-title>
            <source>Neurol Genet</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>e352</fpage>
            <pub-id pub-id-type="pmid">31517061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r150">
          <label>150</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moghadam-Kia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oddis</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Approach to asymptomatic creatine kinase elevation.</article-title>
            <source>Cleve Clin J Med</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">26760521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r151">
          <label>151</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Cabaniss</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <chapter-title>Creatine Kinase</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Walker</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <source>Clinical Methods: The History, Physical, and Laboratory Examinations</source>
            <edition>3rd</edition>
            <publisher-name>Butterworths</publisher-name>
            <publisher-loc>Boston</publisher-loc>
            <year>1990</year>
            <pub-id pub-id-type="pmid">21250193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r152">
          <label>152</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Correlation of Serum Creatine Kinase Level With Pulmonary Function in Duchenne Muscular Dystrophy.</article-title>
            <source>Ann Rehabil Med</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>306</fpage>
            <page-range>306-312</page-range>
            <pub-id pub-id-type="pmid">28503465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r153">
          <label>153</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalyani</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Corriere</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrucci</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.</article-title>
            <source>Lancet Diabetes Endocrinol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>10</issue>
            <fpage>819</fpage>
            <page-range>819-29</page-range>
            <pub-id pub-id-type="pmid">24731660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r154">
          <label>154</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drummond</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.</article-title>
            <source>Arch Dis Child</source>
            <year>1979</year>
            <month>May</month>
            <volume>54</volume>
            <issue>5</issue>
            <fpage>362</fpage>
            <page-range>362-6</page-range>
            <pub-id pub-id-type="pmid">475411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r155">
          <label>155</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Percy</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Oss</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Verellen-Dumoulin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.</article-title>
            <source>Muscle Nerve</source>
            <year>1979</year>
            <season>Sep-Oct</season>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>329</fpage>
            <page-range>329-39</page-range>
            <pub-id pub-id-type="pmid">492209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r156">
          <label>156</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bonne</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leturcq</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ben Yaou</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Emery-Dreifuss Muscular Dystrophy</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2004</year>
            <month>9</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">20301609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r157">
          <label>157</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeshima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ariyasu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ishibashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uraki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Akamizu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency.</article-title>
            <source>Endocrinol Diabetes Metab Case Rep</source>
            <year>2018</year>
            <volume>2018</volume>
            <pub-id pub-id-type="pmid">29367875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r158">
          <label>158</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Lindquist</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Serai</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Mariappan</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Merrow</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Ehman</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Laor</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Magnetic resonance imaging of pediatric muscular disorders: recent advances and clinical applications.</article-title>
            <source>Radiol Clin North Am</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>721</fpage>
            <page-range>721-42</page-range>
            <pub-id pub-id-type="pmid">23830795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r159">
          <label>159</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Gidali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Deformity or dysfunction? Osteopathic manipulation of the idiopathic cavus foot: A clinical suggestion.</article-title>
            <source>N Am J Sports Phys Ther</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-32</page-range>
            <pub-id pub-id-type="pmid">21509155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r160">
          <label>160</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilaslan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Shives</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Unni</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Unilateral hypertrophy of tensor fascia lata: a soft tissue tumor simulator.</article-title>
            <source>Skeletal Radiol</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>32</volume>
            <issue>11</issue>
            <fpage>628</fpage>
            <page-range>628-32</page-range>
            <pub-id pub-id-type="pmid">14586575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r161">
          <label>161</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grimm</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kress</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Risk assessment and genetic counseling in families with Duchenne muscular dystrophy.</article-title>
            <source>Acta Myol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>179</fpage>
            <page-range>179-83</page-range>
            <pub-id pub-id-type="pmid">23620649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r162">
          <label>162</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy.</article-title>
            <source>J Pers Med</source>
            <year>2019</year>
            <month>Mar</month>
            <day>04</day>
            <volume>9</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30836656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r163">
          <label>163</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pastore</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Samesima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pereira-Filho</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>III SBC Guidelines on the Analysis and Issuance of Electrocardiographic Reports - Executive Summary.</article-title>
            <source>Arq Bras Cardiol</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>107</volume>
            <issue>5</issue>
            <fpage>392</fpage>
            <page-range>392-402</page-range>
            <pub-id pub-id-type="pmid">27982266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r164">
          <label>164</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarubbi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Somerville</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>QRS width in right bundle branch block. Accuracy and reproducibility of manual measurement.</article-title>
            <source>Int J Cardiol</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-4</page-range>
            <pub-id pub-id-type="pmid">11054509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r165">
          <label>165</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nikoli&#x00107;</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Dominant R wave in lead V1.</article-title>
            <source>Heart Lung</source>
            <year>1998</year>
            <season>Sep-Oct</season>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>352</fpage>
            <page-range>352-3</page-range>
            <pub-id pub-id-type="pmid">9777382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r166">
          <label>166</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thrush</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Viollet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mendell</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy.</article-title>
            <source>Am J Cardiol</source>
            <year>2009</year>
            <month>Jan</month>
            <day>15</day>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>262</fpage>
            <page-range>262-5</page-range>
            <pub-id pub-id-type="pmid">19121448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r167">
          <label>167</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koene</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Adkisson</surname>
                <given-names>WO</given-names>
              </name>
              <name>
                <surname>Benditt</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.</article-title>
            <source>J Arrhythm</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>533</fpage>
            <page-range>533-544</page-range>
            <pub-id pub-id-type="pmid">29255498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r168">
          <label>168</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Groh</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kincaid</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ciafaloni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pourmand</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Otten</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Bhakta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Marashdeh</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Zipes</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Pascuzzi</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Jun</month>
            <day>19</day>
            <volume>358</volume>
            <issue>25</issue>
            <fpage>2688</fpage>
            <page-range>2688-97</page-range>
            <pub-id pub-id-type="pmid">18565861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r169">
          <label>169</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Segawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Komaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mori-Yoshimura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tachimori</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Cardiac conduction disturbances and aging in patients with Duchenne muscular dystrophy.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>96</volume>
            <issue>42</issue>
            <fpage>e8335</fpage>
            <pub-id pub-id-type="pmid">29049249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r170">
          <label>170</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paganoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amato</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Electrodiagnostic evaluation of myopathies.</article-title>
            <source>Phys Med Rehabil Clin N Am</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>193</fpage>
            <page-range>193-207</page-range>
            <pub-id pub-id-type="pmid">23177039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r171">
          <label>171</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cannon</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Channelopathies of skeletal muscle excitability.</article-title>
            <source>Compr Physiol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>761</fpage>
            <page-range>761-90</page-range>
            <pub-id pub-id-type="pmid">25880512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r172">
          <label>172</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA.</article-title>
            <source>Lancet</source>
            <year>1991</year>
            <month>Feb</month>
            <day>23</day>
            <volume>337</volume>
            <issue>8739</issue>
            <fpage>504</fpage>
            <pub-id pub-id-type="pmid">1704092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r173">
          <label>173</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Sherif</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Fahmy</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Nonaka</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Etribi</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Patterns of dystrophin gene deletion in Egyptian Duchenne/Becker muscular dystrophy patients.</article-title>
            <source>Acta Myol</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-50</page-range>
            <pub-id pub-id-type="pmid">18646563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r174">
          <label>174</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sbiti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>El Kerch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sefiani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Dystrophin Gene Deletions by Multiplex PCR in Moroccan Patients.</article-title>
            <source>J Biomed Biotechnol</source>
            <year>2002</year>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>158</fpage>
            <page-range>158-160</page-range>
            <pub-id pub-id-type="pmid">12488581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r175">
          <label>175</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Bentley</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Bobrow</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene.</article-title>
            <source>Genomics</source>
            <year>1990</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>602</fpage>
            <page-range>602-6</page-range>
            <pub-id pub-id-type="pmid">1974880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r176">
          <label>176</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barresi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies.</article-title>
            <source>Skelet Muscle</source>
            <year>2011</year>
            <month>Jun</month>
            <day>24</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <pub-id pub-id-type="pmid">21798100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r177">
          <label>177</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Gabbai</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kiyomoto</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Minetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonilla</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry.</article-title>
            <source>Arq Neuropsiquiatr</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>478</fpage>
            <page-range>478-85</page-range>
            <pub-id pub-id-type="pmid">1309152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r178">
          <label>178</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Le Thanh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meinke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korfali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Srsen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Wehnert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schoser</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sewry</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Schirmer</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Immunohistochemistry on a panel of Emery-Dreifuss muscular dystrophy samples reveals nuclear envelope proteins as inconsistent markers for pathology.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <page-range>338-351</page-range>
            <pub-id pub-id-type="pmid">28214269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r179">
          <label>179</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertrand</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>B&#x000f6;nnemann</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Bonne</surname>
                <given-names>G</given-names>
              </name>
              <collab>FHL1 myopathy consortium</collab>
            </person-group>
            <article-title>199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2014</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>453</fpage>
            <page-range>453-62</page-range>
            <pub-id pub-id-type="pmid">24613424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r180">
          <label>180</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Folker</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Baylies</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Nuclear positioning in muscle development and disease.</article-title>
            <source>Front Physiol</source>
            <year>2013</year>
            <month>Dec</month>
            <day>12</day>
            <volume>4</volume>
            <fpage>363</fpage>
            <pub-id pub-id-type="pmid">24376424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r181">
          <label>181</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peverelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Testolin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petrini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Favero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Magri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Morandi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mongini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sciacco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Moggio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy.</article-title>
            <source>Neurology</source>
            <year>2015</year>
            <month>Nov</month>
            <day>24</day>
            <volume>85</volume>
            <issue>21</issue>
            <fpage>1886</fpage>
            <page-range>1886-93</page-range>
            <pub-id pub-id-type="pmid">26497992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r182">
          <label>182</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tasca</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Fatigue in muscular dystrophies.</article-title>
            <source>Neuromuscul Disord</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>22 Suppl 3</volume>
            <issue>3-3</issue>
            <fpage>S214</fpage>
            <page-range>S214-20</page-range>
            <pub-id pub-id-type="pmid">23182642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r183">
          <label>183</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guilleminault</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Philip</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-32</page-range>
            <pub-id pub-id-type="pmid">9703177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r184">
          <label>184</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reardon</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>MacMillan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Myring</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harley</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Rundle</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Cataract and myotonic dystrophy: the role of molecular diagnosis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1993</year>
            <month>Sep</month>
            <volume>77</volume>
            <issue>9</issue>
            <fpage>579</fpage>
            <page-range>579-83</page-range>
            <pub-id pub-id-type="pmid">8218057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r185">
          <label>185</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Darras</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Urion</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <chapter-title>Dystrophinopathies</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2000</year>
            <month>9</month>
            <day>5</day>
            <pub-id pub-id-type="pmid">20301298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r186">
          <label>186</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palladino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Ambrosio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Papa</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Petillo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Orsini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scutifero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nigro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Politano</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.</article-title>
            <source>Acta Myol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>128</fpage>
            <page-range>128-134</page-range>
            <pub-id pub-id-type="pmid">28484313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r187">
          <label>187</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Groh</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.</article-title>
            <source>Neurology</source>
            <year>2011</year>
            <month>Jan</month>
            <day>25</day>
            <volume>76</volume>
            <issue>4</issue>
            <fpage>409; author reply 409</fpage>
            <pub-id pub-id-type="pmid">21263144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r188">
          <label>188</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stunnenberg</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Woertman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Raaphorst</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Statland</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Griggs</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Timmermans</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Saris</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Schouwenberg</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Groenewoud</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Stegeman</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>van Engelen</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Drost</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>van der Wilt</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.</article-title>
            <source>BMC Neurol</source>
            <year>2015</year>
            <month>Mar</month>
            <day>25</day>
            <volume>15</volume>
            <fpage>43</fpage>
            <pub-id pub-id-type="pmid">25880166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r189">
          <label>189</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Topaloglu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gloss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moxley</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Ashwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oskoui</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology.</article-title>
            <source>Neurology</source>
            <year>2016</year>
            <month>Jul</month>
            <day>12</day>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>238</fpage>
            <pub-id pub-id-type="pmid">27402942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r190">
          <label>190</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peterle</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.</article-title>
            <source>Acta Myol</source>
            <year>2012</year>
            <month>May</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-15</page-range>
            <pub-id pub-id-type="pmid">22655511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r191">
          <label>191</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guglieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bushby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Tawil</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Herr</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>McColl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirschner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Willis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirtz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shieh</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Straub</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Childs</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ciafaloni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Butterfield</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Horrocks</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Spinty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Flanigan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kuntz</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Baranello</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Roper</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mah</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Manzur</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Schara</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>von der Hagen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barohn</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Darras</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Finkel</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Vita</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mongini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pegoraro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wicklund</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilichowski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bryan Burnette</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>McMillan</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Thangarajh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Griggs</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.</article-title>
            <source>Contemp Clin Trials</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>58</volume>
            <fpage>34</fpage>
            <page-range>34-39</page-range>
            <pub-id pub-id-type="pmid">28450193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r192">
          <label>192</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic advances in muscular dystrophy.</article-title>
            <source>Ann Neurol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>74</volume>
            <issue>3</issue>
            <fpage>404</fpage>
            <page-range>404-11</page-range>
            <pub-id pub-id-type="pmid">23939629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r193">
          <label>193</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Day</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ricker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Kress</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Beilman</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Ranum</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.</article-title>
            <source>Neurology</source>
            <year>2003</year>
            <month>Feb</month>
            <day>25</day>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>657</fpage>
            <page-range>657-64</page-range>
            <pub-id pub-id-type="pmid">12601109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r194">
          <label>194</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Preston</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Tawil</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <chapter-title>Facioscapulohumeral Muscular Dystrophy</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1999</year>
            <month>3</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">20301616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r195">
          <label>195</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsao</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Mendell</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Coexisting muscular dystrophies and epilepsy in children.</article-title>
            <source>J Child Neurol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>148</fpage>
            <page-range>148-50</page-range>
            <pub-id pub-id-type="pmid">16566880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r196">
          <label>196</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eccleston</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Aug</month>
            <day>02</day>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>CD012537</fpage>
            <pub-id pub-id-type="pmid">28770976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r197">
          <label>197</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>KRQ</given-names>
              </name>
              <name>
                <surname>Yokota</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Invention and Early History of Exon Skipping and Splice Modulation.</article-title>
            <source>Methods Mol Biol</source>
            <year>2018</year>
            <volume>1828</volume>
            <fpage>3</fpage>
            <page-range>3-30</page-range>
            <pub-id pub-id-type="pmid">30171532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r198">
          <label>198</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yokota</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy.</article-title>
            <source>J Pers Med</source>
            <year>2017</year>
            <month>Oct</month>
            <day>16</day>
            <volume>7</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">29035327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r199">
          <label>199</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sussman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Duchenne muscular dystrophy.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2002</year>
            <season>Mar-Apr</season>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-51</page-range>
            <pub-id pub-id-type="pmid">11929208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r200">
          <label>200</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciudin</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Dragatoiu</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Sipos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tesloianu</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Ursaru</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Brezeanu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coman</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Fast Progressing His-Purkinje Conduction Disturbances in a Myotonic Dystrophy Pacient.</article-title>
            <source>Maedica (Bucur)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-154</page-range>
            <pub-id pub-id-type="pmid">30069244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r201">
          <label>201</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Altekin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Yanikoglu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ucar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ermis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Complete AV block and cardiac syncope in a patient with Duchenne muscular dystrophy.</article-title>
            <source>J Cardiol Cases</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>e68</fpage>
            <page-range>e68-e70</page-range>
            <pub-id pub-id-type="pmid">30532840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r202">
          <label>202</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Copeland</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Dodenhoff</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>The shoulder in patients with muscular dystrophy.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1999</year>
            <month>Nov</month>
            <issue>368</issue>
            <fpage>80</fpage>
            <page-range>80-91</page-range>
            <pub-id pub-id-type="pmid">10613155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r203">
          <label>203</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tajrishi</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Wasting mechanisms in muscular dystrophy.</article-title>
            <source>Int J Biochem Cell Biol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>2266</fpage>
            <page-range>2266-79</page-range>
            <pub-id pub-id-type="pmid">23669245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r204">
          <label>204</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Souza</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>de Baptista</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Aldaves</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Mattiello-Sverzut</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Beneficial effects of ankle-foot orthosis daytime use on the gait of Duchenne muscular dystrophy patients.</article-title>
            <source>Clin Biomech (Bristol, Avon)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>35</volume>
            <fpage>102</fpage>
            <page-range>102-10</page-range>
            <pub-id pub-id-type="pmid">27139255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r205">
          <label>205</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nalini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Vengalil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khanna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krishnan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Taly</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Ankle-Foot Orthosis in Duchenne Muscular Dystrophy: A 4&#x000a0;year Experience in a Multidisciplinary Neuromuscular Disorders Clinic.</article-title>
            <source>Indian J Pediatr</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-215</page-range>
            <pub-id pub-id-type="pmid">27815810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r206">
          <label>206</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliv&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kley</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>Myofibrillar myopathies: new developments.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>527</fpage>
            <page-range>527-35</page-range>
            <pub-id pub-id-type="pmid">23995273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r207">
          <label>207</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nigro</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Improving the course of muscular dystrophy?</article-title>
            <source>Acta Myol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <pub-id pub-id-type="pmid">23097600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r208">
          <label>208</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Read</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Donnai</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>What can be offered to couples at (possibly) increased genetic risk?</article-title>
            <source>J Community Genet</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-74</page-range>
            <pub-id pub-id-type="pmid">22760671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r209">
          <label>209</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Stepwise approach to myopathy in systemic disease.</article-title>
            <source>Front Neurol</source>
            <year>2011</year>
            <volume>2</volume>
            <fpage>49</fpage>
            <pub-id pub-id-type="pmid">21886637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r210">
          <label>210</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Passamano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Taglia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palladino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Viggiano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>D'Ambrosio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scutifero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosaria Cecio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>DE Luca</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Picillo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paciello</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Piluso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nigro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Politano</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.</article-title>
            <source>Acta Myol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-5</page-range>
            <pub-id pub-id-type="pmid">23097603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r211">
          <label>211</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gualandi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Petrini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Congenital muscular dystrophies: a brief review.</article-title>
            <source>Semin Pediatr Neurol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>277</fpage>
            <page-range>277-88</page-range>
            <pub-id pub-id-type="pmid">22172424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25401.r212">
          <label>212</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Birnkrant</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bushby</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bann</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Alman</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Apkon</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Blackwell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Case</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Cripe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hadjiyannakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sheehan</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Bolen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>LM</given-names>
              </name>
              <collab>DMD Care Considerations Working Group</collab>
            </person-group>
            <article-title>Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.</article-title>
            <source>Lancet Neurol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>347</fpage>
            <page-range>347-361</page-range>
            <pub-id pub-id-type="pmid">29395990</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
